var title_f2_15_2288="Jersey finger examination";
var content_f2_15_2288=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F65933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F65933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Jersey finger examination",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 415px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Loss of flexion&nbsp;at the distal interphalangeal (DIP) joint of the ring finger is seen&nbsp;when the patient actively makes a fist, suggesting a flexor tendon injury of the DIP joint&nbsp;(ie, Jersey finger).&nbsp;",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rebecca Bassett, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2288=[""].join("\n");
var outline_f2_15_2288=null;
var title_f2_15_2289="Blue toe syndrome";
var content_f2_15_2289=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58761&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58761&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blue toe syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 318px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blue toes are a classic manifestation of peripheral embolization of atheromatous material from proximal arterial sources (eg, aorta); the pedal pulses are often normal. This patient, who has a 30-year history of type 1 diabetes and severe peripheral vascular disease, presented with foot pain and discoloration. Cholesterol microemboli from the aorta were suspected to be the cause.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Lawrence B Stack, MD. Copyright &copy; Lawrence B Stack, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2289=[""].join("\n");
var outline_f2_15_2289=null;
var title_f2_15_2290="Polarized light physics";
var content_f2_15_2290=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F59248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F59248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 622px\">",
"   <div class=\"ttl\">",
"    Polarized light physics",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 602px; height: 188px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Non-polarized light vibrate in different orientations. When non-polarized light is transmitted through a polarizing filter (filter A), the emerging light becomes polarized (vibrations in one plane). Polarized light that maintains its polarization after interacting with the skin is unable to pass through the cross-polarizing filter (filter B) and hence no light will emerge through the cross-polarized filter and the observer will see no structures. Polarized light that interacts with deeper parts of the skin undergoes multiple scattering events resulting in randomization of polarization. The scattered light emerging from the skin that is in the same plane as the cross-polarized filter (filter B) will pass through the filter allowing the observer to recognize structures.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2290=[""].join("\n");
var outline_f2_15_2290=null;
var title_f2_15_2291="Iliac node dissection";
var content_f2_15_2291=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F65246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F65246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Elevating the left common iliac nodes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2291=[""].join("\n");
var outline_f2_15_2291=null;
var title_f2_15_2292="Paraaortic node dissection7";
var content_f2_15_2292=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    View of aorta after paraaortic node dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2292=[""].join("\n");
var outline_f2_15_2292=null;
var title_f2_15_2293="Vulvar cancer 2";
var content_f2_15_2293=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F71378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F71378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 466px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Vulvar carcinoma in situ presenting as white or hyperpigmented lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Scott, JR, Gibbs, RS. Danforth's Obstetrics and Gynecology, Ninth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2293=[""].join("\n");
var outline_f2_15_2293=null;
var title_f2_15_2294="Discordant twin placenta";
var content_f2_15_2294=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F66875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F66875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Discordant twin placenta",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 316px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chorioamnionitis and meconium in twin 1, normal twin 2.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla J Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2294=[""].join("\n");
var outline_f2_15_2294=null;
var title_f2_15_2295="Mifepristone: Patient drug information";
var content_f2_15_2295=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Mifepristone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/45/1753?source=see_link\">",
"     see \"Mifepristone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F196821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Korlym&trade;;",
"     </li>",
"     <li>",
"      Mifeprex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10019521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3683305",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use in pregnant women will cause fetal loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683368",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using to end pregnancy:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If this drug does not cause a full abortion, surgery may be needed. Make sure that you know this drug, what it is for, how to use it, and when to go back to your doctor. You must agree to the abortion and surgery if needed. You must read the medication guide and sign a patient contract form.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700471",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bleeding may happen after use of this drug. Call your doctor right away if you have a lot of bleeding (soaking  one pad per hour) or if you are worried about bleeding. A surgery may be needed.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700510",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad infections may happen after use. Call your doctor if you have an upset stomach, are throwing up, loose stools, or weakness with or without belly pain or fever more than 1 day after use. Very bad belly pain may also be a sign of some other problem. Your doctor will need to check you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700348",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are going to an ER (emergency room) or some other doctor, take the medication guide with you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683389",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using for high blood sugar:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3683411",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. A pregnancy test will be done to show that you are NOT pregnant before starting this drug. Use a helpful kind of birth control while taking this drug and for 1 month after stopping this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691365",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to end your pregnancy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3683870",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower blood sugar in patients with Cushing&rsquo;s syndrome.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019522\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702527",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to mifepristone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701089",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner or are on a long-term steroid, such as prednisone.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683368",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using to end pregnancy:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703217",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Adrenal failure, bleeding problems, porphyrias, or pregnancy where the fertilized egg was not in a normal position.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703163",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an IUD (intrauterine device) in place.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701335",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to follow what your doctor gives you or you are not able to get to an ER (emergency room) if you need one.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 7 weeks pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683389",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using for high blood sugar:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3683746",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Change in the cells lining your uterus, endometrial cancer, or vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3683814",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you do not have Cushing&rsquo;s syndrome.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10019527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697168",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have anemia, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683368",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using to end pregnancy:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697807",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You must make 3 visits to your doctor (days 1, 2, and 14).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697012",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a heavy smoker, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After ending pregnancy, use birth control that you can trust.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683389",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using for high blood sugar:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697297",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have low potassium levels, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697234",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had an organ transplant, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697732",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug and for 1 month after stopping this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10019528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698384",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Vaginal bleeding. There may be more bleeding than from a heavy period.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698210",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood sugar may occur. Signs may be dizziness, headache, feeling sleepy, feeling weak, shaking, a fast heartbeat, confusion, hunger, or sweating. Keep hard candies, glucose tablets, liquid glucose, or juice on hand for low blood sugar.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10019530\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698648",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding a lot (soaking 1 pad per hour).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699138",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3546452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699116",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weakness with or without belly pain and fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, period changes. These include lots of bleeding, spotting, or bleeding between cycles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10019525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683368",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using to end pregnancy:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696083",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use this drug as ordered by your doctor. Read and follow the dosing on the label closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683389",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using for high blood sugar:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695929",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10019526\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683368",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using to end pregnancy:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683389",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using for high blood sugar:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10019531\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683368",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using to end pregnancy:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3683389",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         If using for high blood sugar:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10019532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10868 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-C88E1676B6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2295=[""].join("\n");
var outline_f2_15_2295=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196821\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019521\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019523\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019522\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019527\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019528\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019530\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019525\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019526\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019531\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019532\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?1/45/1753?source=related_link\">",
"      Mifepristone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_15_2296="Hereditary diffuse gastric cancer";
var content_f2_15_2296=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hereditary diffuse gastric cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/15/2296/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2296/contributors\">",
"     Debrah Wirtzfeld, MD, MSc, FRCSC, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2296/contributors\">",
"     Kasmintan A Schrader, MBBS, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/15/2296/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2296/contributors\">",
"     Richard M Goldberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/15/2296/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2296/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/15/2296/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hereditary diffuse gastric cancer (HDGC) is an inherited form of diffuse type gastric cancer, a highly invasive tumor that is characterized by late presentation and a poor prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Diffuse carcinomas display a prominent molecular abnormality: defective intercellular adhesions, which can result from loss of expression of the cell adhesion protein E-cadherin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33194?source=see_link&amp;anchor=H14#H14\">",
"     \"Pathology and molecular pathogenesis of gastric cancer\", section on 'Diffuse type cancers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many families with HDGC have germline mutations in the E-cadherin (CDH1) gene that are inherited in an autosomal dominant pattern. The lifetime cumulative risk for clinically significant gastric cancer in individuals from these families is &gt;80 percent in both men and women by age 80 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/4\">",
"     4",
"    </a>",
"    ]; the median age at diagnosis is 38. Because these early gastric cancers are located beneath an intact mucosal surface, early detection is extremely difficult, and prophylactic total gastrectomy is usually advised after age 20, and before the age of 40.",
"   </p>",
"   <p>",
"    This topic will provide a detailed overview of HDGC, focusing on the identification of high-risk families and genetic counseling and testing. The molecular pathogenesis of this disorder and technical aspects of prophylactic total gastrectomy for patients with HDGC are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33194?source=see_link&amp;anchor=H14#H14\">",
"     \"Pathology and molecular pathogenesis of gastric cancer\", section on 'Diffuse type cancers'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/34/3625?source=see_link\">",
"     \"Prophylactic total gastrectomy for hereditary diffuse gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MOLECULAR GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;HDGC is inherited as an autosomal dominant trait with high penetrance. Germline truncating mutations of the CDH1 gene, located on chromosome 16q22.1, were originally described in three Maori families from New Zealand that were predisposed to diffuse gastric cancer. Subsequently, germline CDH1 mutations have been identified in approximately 25 to 50 percent of affected kindreds that meet the clinical criteria for HDGC, as defined by the International Gastric Cancer Linkage Consortium (IGCLC, see below [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/4\">",
"     4",
"    </a>",
"    ]).",
"    <br/>",
"    <br/>",
"    The frequency of mutation detection varies inversely with the background incidence of gastric cancer. Thus CDH1 mutation detection rates in families meeting HDGC criteria are highest (52.6 percent) in lower-incidence countries like Canada, the United States, and the United Kingdom [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/5\">",
"     5",
"    </a>",
"    ] and lower in moderate-incidence countries like Germany (25 percent), and lowest in high-incidence countries like Portugal and Italy (22.2 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/5\">",
"     5",
"    </a>",
"    ] and Japan (15.4 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/6\">",
"     6",
"    </a>",
"    ]. Of clinical importance, in low incidence countries, the criteria used to define HDGC can be relaxed with little effect on mutation detection rates [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The majority of germline mutations identified to date have been single nucleotide substitutions leading to non-synonymous changes (splice site or truncating mutations), or up to several base-pair insertions or deletions leading to frameshifts and protein truncation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/1,2,7-38\">",
"     1,2,7-38",
"    </a>",
"    ]. Four percent of familial cases are due to large deletions involving multiple exons of the gene [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/5\">",
"     5",
"    </a>",
"    ]. All germline mutations are evenly distributed along the gene and lead to functional haploinsufficiency of E-cadherin.",
"   </p>",
"   <p>",
"    The trigger and molecular mechanism by which the second allele of E-cadherin is inactivated appears to be diverse, and includes promoter hypermethylation, mutation, and loss of heterozygosity. The end result is loss of expression of the cell adhesion molecule E-cadherin. This topic is discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33194?source=see_link&amp;anchor=H15#H15\">",
"     \"Pathology and molecular pathogenesis of gastric cancer\", section on 'Molecular pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Risk of cancer in mutation carriers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lifetime cumulative risk for advanced gastric cancer in patients with germline mutations of CDH1 has been updated to &gt;80 percent in both men and women by age 80 years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/4\">",
"     4",
"    </a>",
"    ]; this increased estimate balances the sex differential present in previous estimates of 40 to 70 percent in men and 60 to 80 percent in women [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/7,15\">",
"     7,15",
"    </a>",
"    ]. The average age of onset of HDGC is 38 years, although it ranges from 14 to 82 years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Risk of other cancers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Family members of known gene mutation carriers are also at high risk of developing lobular breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/8,15,39-41\">",
"     8,15,39-41",
"    </a>",
"    ]. Women with CDH1 germline mutations have a 60 percent risk of developing lobular breast cancer by age 80 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/4\">",
"     4",
"    </a>",
"    ]; this updated risk is increased from original estimates of 40 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/1\">",
"     1",
"    </a>",
"    ]. The optimal breast cancer screening strategy in such women is unclear. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=see_link&amp;anchor=H69480723#H69480723\">",
"     \"Characteristics of hereditary breast and ovarian cancer syndromes\", section on 'Inherited CDH1 mutations and hereditary diffuse gastric cancer syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     IDENTIFICATION OF HIGH-RISK FAMILIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of a CDH1 gene mutation in a family is usually recognized when a case of diffuse gastric cancer occurs in a family member under the age of 50 or when there are several cases in one family.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Genetic counseling and testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of gastric cancer in asymptomatic carriers of germline mutations in E-cadherin who belong to families with highly penetrant HDGC is sufficiently high to warrant genetic counseling for germline mutation testing and consideration of prophylactic total gastrectomy (PTG) for mutation carriers [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The optimal timing of surgery is debated. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Prophylactic gastrectomy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Criteria for genetic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The detection rate for CDH1 mutations is about 25 to 50 percent when the following clinical criteria are used for inclusion: histologically confirmed diffuse gastric cancer in three first degree family members at any age, or two or more gastric cancers in first degree relatives with at least one confirmed case of diffuse gastric cancer diagnosed before the age of 50 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/7,24,27,44\">",
"     7,24,27,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Consensus-based criteria for identifying mutation-positive families were initially developed by the Gastric Cancer Linkage Consortium at the first meeting of the International Gastric Cancer Linkage Consortium (IGCLC) in 2000 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/45\">",
"     45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      &ge;2 cases of diffuse type gastric cancer in",
"      <span class=\"nowrap\">",
"       first/second",
"      </span>",
"      degree relatives with one &lt;50 years old &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    OR",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      &ge;3 cases of diffuse type gastric cancer in",
"      <span class=\"nowrap\">",
"       first/second",
"      </span>",
"      degree relatives of any age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The proportion of patients fulfilling these criteria was examined and detection rates were 22.2 percent in countries with high incidences of gastric cancer and 52.6 percent in countries with low background rates [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1391653\">",
"    <span class=\"h4\">",
"     Expanded criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Modified criteria for selection of patients for genetic testing for HDGC have been proposed based upon the experience of the British Columbia Cancer Agency Hereditary Diffuse Gastric Cancer Program [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/7,46\">",
"     7,46",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Families with two or more documented cases of gastric cancer in first or second degree relatives, with at least one diffuse gastric cancer diagnosed before age 50 years",
"     </li>",
"     <li>",
"      Families with multiple lobular breast cancers with or without diffuse gastric cancer in first or second degree relatives",
"     </li>",
"     <li>",
"      Individual diagnosed with diffuse gastric cancer before 35 years of age from a low incidence population",
"     </li>",
"     <li>",
"      Potential additional criteria which need additional validation in clinical studies include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Three or more cases of gastric cancer in first or second degree relatives, diagnosed at any age, one or more of which is a documented case of diffuse gastric cancer (3 percent mutation rate; 1",
"      <span class=\"nowrap\">",
"       positive/30",
"      </span>",
"      tested)",
"     </li>",
"     <li>",
"      Family with one or more cases of both diffuse gastric cancer and signet ring colon cancer (33 percent mutation rate; 1",
"      <span class=\"nowrap\">",
"       positive/3",
"      </span>",
"      tested).",
"     </li>",
"     <li>",
"      Personal history but no family history of diffuse gastric cancer or lobular breast cancer (mutation rate unknown)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These criteria which have mainly been applied to families from low incidence countries, such as Canada and the United States, have been shown to yield a comparable (54 percent) detection rate as does the criteria initially proposed by the International Gastric Cancer Linkage Consortium (IGCLC) in 2000 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/45\">",
"     45",
"    </a>",
"    ] ( two or more documented cases of gastric cancer in first or second degree relatives, with at least one diffuse gastric cancer diagnosed before age 50 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Families with multiple lobular breast cancers and no apparent cases of diffuse gastric cancer can harbor germline mutations in CDH1 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/47-49\">",
"     47-49",
"    </a>",
"    ], although these families appear to be rare. When familial breast cancer families are selected on the basis of a proband with either early-onset lobular breast cancer or lobular breast cancer and a family history of breast cancer (without confirmation of multiple lobular breast cancers), the detection rate is low [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 2010, the International Gastric Cancer Linkage Consortium (IGCLC) broadened the consensus guidelines for CDH1 mutation testing to include [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Two gastric cancer cases in family, one confirmed diffuse gastric cancer under age 50",
"     </li>",
"     <li>",
"      Three confirmed diffuse gastric cancer cases in first or second degree relatives independent of age",
"     </li>",
"     <li>",
"      Diffuse gastric cancer in an individual under the age of 40",
"     </li>",
"     <li>",
"      Personal or family history of diffuse gastric cancer and lobular breast cancer, one diagnosed under the age of 50",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Consortium also supported the inclusion of cases where expert pathologists detect in situ signet ring cells",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pagetoid spread of signet ring cells adjacent to diffuse type gastric cancer, given that this is rarely if ever seen in sporadic cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Performance of genetic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A blood sample from an affected family member is the best substrate for index testing [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/46\">",
"     46",
"    </a>",
"    ]. Testing can also be achieved on DNA extracted from saliva. If unable to test an affected family member, another option is testing a sample from an unaffected relative who might be an obligate carrier. Although HDGC is inherited as an autosomal dominant trait, and most patients who inherit the mutation will have the disease, 20 percent of carriers will not develop clinically significant disease; therefore in some cases, an unaffected obligate carrier can be identified. As an example, suppose that the index case had two unaffected parents. If there is evidence of affected members on one side of the family (for example, a maternal aunt was affected), then it is most likely that the mutation was inherited from an unaffected carrier mother, and she would be the most likely candidate for testing.",
"   </p>",
"   <p>",
"    Another option is to test DNA from archived paraffin blocks from an affected family member. &nbsp;This is often impractical and should only be considered as a last resort.",
"   </p>",
"   <p>",
"    Mutation testing is usually accomplished by direct sequencing of all coding regions of the gene including intron-exon boundaries [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/7\">",
"     7",
"    </a>",
"    ]. Several different types of mutations can be found in HDGC families by sequencing, including nonsynonymous",
"    <span class=\"nowrap\">",
"     (missense/nonsense),",
"    </span>",
"    indels (in-frame",
"    <span class=\"nowrap\">",
"     /frameshift),",
"    </span>",
"    and splice site mutations. It is not known whether there are any",
"    <span class=\"nowrap\">",
"     genotypic/phenotype",
"    </span>",
"    correlations, and in particular, if any of the specific mutations in CDH1 are associated with a different risk of gastric cancer. Once a family mutation has been identified, it is simple to set up a mutation-specific assay to assess the mutation status of family members.",
"   </p>",
"   <p>",
"    Some intragenic deletions have been discovered in families where no mutation was evident by sequencing [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/5\">",
"     5",
"    </a>",
"    ]. Thus, screening for large genomic deletions with multiplex ligation-dependent probe amplification (MLPA) or alternative methods is recommended in cases where DNA sequencing is unrevealing.",
"   </p>",
"   <p>",
"    The optimal age to screen individuals from affected families is unclear. Rare cases of diffuse gastric cancer have been reported in affected families before the age of 18, but the overall risk of cancer before age 20 is very low (less than 1 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/7,15\">",
"     7,15",
"    </a>",
"    ]. Most groups agree that consideration of genetic testing can begin at 16 or 18 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/39\">",
"     39",
"    </a>",
"    ]. However, decisions as to the age at which to institute testing should also take into account the earliest age of cancer onset in the individual family.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF MUTATION CARRIERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rare cases of diffuse gastric cancer have been reported in affected families before the age of 18, but the overall risk of cancer before age 20 is very low (less than 1 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/7,15\">",
"     7,15",
"    </a>",
"    ]. The risk rises to 4 percent by age 30 without prophylactic surgery.",
"   </p>",
"   <p>",
"    There are no reliable screening tests that allow early diagnosis of diffuse gastric cancers in mutation carriers [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/52\">",
"     52",
"    </a>",
"    ]. The gastric cancers that arise in patients with HDGC are located beneath an intact surface epithelium and only become visible on direct mucosal evaluation late in the disease process [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. As a result, for individuals who test positive for a CDH1 mutation, prophylactic gastrectomy is usually recommended after age 20. Mutation carriers who are identified prior to age 20 may be recommended to undergo annual surveillance endoscopy. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Prophylactic gastrectomy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    However, the timing of the operation may vary according to the preferences, age, and physical as well as psychological fitness of the individual. Annual surveillance endoscopy with random biopsies may be considered for patients who receive a recommendation for prophylactic gastrectomy, but who decide to postpone or refuse the procedure due to young age, fertility concerns, or fear of surgery with accompanying complications. Another scenario in which endoscopic surveillance may be considered is in individuals with mutations of undetermined significance, and in those in whom a mutation cannot be identified in the index case. However, in all cases, patients should be counseled as to the focal nature of these endoscopically invisible lesions, and the possibility that they will not be detected by the surveillance procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Endoscopic assessment for gastric cancer",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Serial endoscopy with random biopsies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surveillance endoscopy should ideally be performed in a center with a special interest in and experience with HDGC. Endoscopy should be performed using a white light high definition endoscope, with careful inspection of the mucosa and multiple biopsies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Early detection with direct endoscopic visualization is extremely difficult. The cancerous infiltrates are small and widely distributed, making them difficult to identify with random biopsies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. Multiple endoscopic sampling increases the yield, but still misses early stage disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/58-61\">",
"     58-61",
"    </a>",
"    ]. As an example, in one report of 23 mutation positive patients undergoing PTG, 22 (96 percent) had multifocal, microscopic foci of signet ring adenocarcinoma identified with rigorous pathological reporting [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/58\">",
"     58",
"    </a>",
"    ]. However, only two of these patients (9 percent) were identified by preoperative endoscopic evaluation consisting of at least 15 random mucosal biopsies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Chromoendoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chromoendoscopy, which involves the use of stains or dyes during endoscopy to improve the visualization and characterization of the gastrointestinal mucosa, has been proposed as a highly sensitive method of endoscopic surveillance for CDH1 mutation carriers from high-risk families [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/56,62\">",
"     56,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One group reported success in a series of patients evaluated preoperatively by chromoendoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/62\">",
"     62",
"    </a>",
"    ]. Using a combination of",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"      methylene blue",
"     </a>",
"     /congo",
"    </span>",
"    red staining in 33 mutation carriers over a period of five years, from one to six pale regions felt to represent early disease in 24 of 93 procedures (26 percent) were identified. One biopsy was taken from each pale region and signet ring adenocarcinoma was diagnosed in 23 of 56 lesions (41 percent) or 10 of 33 patients. It was shown that disease was successfully identified in foci &gt;4 mm in size. This has not been replicated in other centers. As an example, in a prospective series of 18 consecutive patients with CDH1 mutations undergoing total gastrectomy at a median age of 45, 17 were found to have a signet ring cell adenocarcinoma; only 2 of 12 asymptomatic patients had it diagnosed preoperatively despite chromoendoscopy with multiple gastric biopsies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The experience from this institution has not been replicated in other centers. Furthermore, congo red is no longer available for this use due to concerns over toxicity. Other chromoendoscopic techniques are currently not recommended except in the research setting. Chromoendoscopy is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15370?source=see_link\">",
"     \"Chromoendoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     PET scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is proposed that glucose metabolism is enhanced in diffuse gastric cancer and that this can be detected using 18-fluoro-deoxyglucose PET scanning.",
"   </p>",
"   <p>",
"    A single case report details the diagnosis of HDGC in an asymptomatic 38-year old CDH1 mutation carrier using (FDG-PET) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/64\">",
"     64",
"    </a>",
"    ]. Upper gastrointestinal endoscopies had been negative, but one of 40 random biopsies showed well differentiated signet cell adenocarcinoma. A PET scan demonstrated two areas of FDG accumulation, one in the proximal stomach, and one in the region of the pylorus. A total gastrectomy specimen demonstrated focal intramucosal adenocarcinoma of the signet cell type in the cardiac and antrum area, at locations that matched the PET scan abnormalities.",
"   </p>",
"   <p>",
"    While intriguing, until further data are available, this approach cannot be recommended as an alternative to early prophylactic gastrectomy in mutation carriers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Prophylactic gastrectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylactic total gastrectomy could reasonably be considered in any individual with an appropriate pedigree that has been shown to have a mutation in the CDH1 gene leading to a truncation of the E-cadherin protein product with resultant loss of function [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/39,42,43,59\">",
"     39,42,43,59",
"    </a>",
"    ]. The two questions that remain unanswered are the utility of prophylactic gastrectomy in patients from high risk families who do not carry the inherited germline mutation, and the age at which to recommend the procedure.",
"   </p>",
"   <p>",
"    While the mean age of onset of diffuse gastric cancer is approximately 38, there are certain kindreds where the mean age of onset is much younger. Gastrectomy is often advised in the early twenties, but some suggest consideration of total gastrectomy in CDH1 mutation carriers at an age five years younger than the youngest family member who developed gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who receive a recommendation for prophylactic gastrectomy may understandably decide to postpone or refuse the procedure due to young age, fertility concerns, or fear of surgery with accompanying complications, although there are reports of successful pregnancies post prophylactic gastrectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2296/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In this setting, close endoscopic surveillance may be the only available option. However, given the unreliability of the available tests for screening and follow up of mutation carriers, we recommend that patients be fully educated about the shortcomings of this approach and encouraged to undergo prophylactic surgery or enroll in clinical research protocols. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Endoscopic assessment for gastric cancer'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Prophylactic gastrectomy for patients with HDGC is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/34/3625?source=see_link\">",
"     \"Prophylactic total gastrectomy for hereditary diffuse gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Screening for breast cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the increased risk of lobular breast cancer in females who carry pathogenic CDH1 mutations, referral to a high-risk breast cancer clinic and enhanced breast cancer screening should be strongly considered. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Risk of other cancers'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=see_link\">",
"     \"Characteristics of hereditary breast and ovarian cancer syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hereditary diffuse gastric cancer (HDGC) is an inherited form of diffuse type gastric cancer. Germline mutations of the CDH1 gene, located on chromosome 16q22.1 have been identified in approximately 25 to 50 percent of affected kindreds with HDGC worldwide. The trigger and molecular mechanism by which the second allele of E-cadherin is inactivated appears to be diverse, and includes promoter hypermethylation, mutation, and loss of heterozygosity. The end result is loss of expression of the cell adhesion molecule E-cadherin. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Molecular genetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HDGC is inherited as an autosomal dominant trait with high penetrance. The lifetime cumulative risk for advanced gastric cancer in individuals with a germline CDH1 mutation is &gt;80 percent in both men and women. Affected patients generally develop gastric cancer at an average age of 38 years. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Risk of cancer in mutation carriers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women in HDGC families are also at high risk of developing lobular breast cancer. They should be referred to a high-risk breast cancer clinic and considered for enhanced breast cancer screening. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Risk of other cancers'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Screening for breast cancer'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Consensus-based criteria are available to identify which patients with diffuse gastric cancer or a family history of gastric cancer should be referred for genetic testing. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Criteria for genetic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mutation testing is usually accomplished by direct sequencing and large deletion analysis if sequencing is unrevealing. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Performance of genetic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prophylactic total gastrectomy is the recommended approach in patients who are carriers of a germline CDH1 mutation. The appropriate age at which to perform gastrectomy is debated, but it may in part be dependent on the pattern of penetrance within the kindred. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Prophylactic gastrectomy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/34/3625?source=see_link\">",
"       \"Prophylactic total gastrectomy for hereditary diffuse gastric cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Annual surveillance endoscopy with random biopsies may be considered for patients who receive a recommendation for prophylactic gastrectomy, but who decide to postpone or refuse the procedure. Another scenario in which endoscopic surveillance may be considered is in individuals with variants of unknown significance and in those in whom a mutation cannot be identified in the index case. However, in all cases, patients should be counseled as to the focal nature of these endoscopically invisible lesions, and the possibility that they will not be detected by the surveillance procedure. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Endoscopic assessment for gastric cancer'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/1\">",
"      Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/2\">",
"      Gayther SA, Gorringe KL, Ramus SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998; 58:4086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/3\">",
"      Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000; 26:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/4\">",
"      Fitzgerald RC, Hardwick R, Huntsman D, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 2010; 47:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/5\">",
"      Oliveira C, Senz J, Kaurah P, et al. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009; 18:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/6\">",
"      Yamada H, Shinmura K, Ito H, et al. Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population. Cancer Sci 2011; 102:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/7\">",
"      Kaurah P, MacMillan A, Boyd N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007; 297:2360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/8\">",
"      Keller G, Vogelsang H, Becker I, et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 1999; 155:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/9\">",
"      Shinmura K, Kohno T, Takahashi M, et al. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis 1999; 20:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/10\">",
"      Richards FM, McKee SA, Rajpar MH, et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 1999; 8:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/11\">",
"      Guilford PJ, Hopkins JB, Grady WM, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999; 14:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/12\">",
"      Yoon KA, Ku JL, Yang HK, et al. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet 1999; 44:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/13\">",
"      Ikonen T, Matikainen M, Mononen N, et al. Association of E-cadherin germ-line alterations with prostate cancer. Clin Cancer Res 2001; 7:3465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/14\">",
"      Dussaulx-Garin L, Blayau M, Pagenault M, et al. A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination. Eur J Gastroenterol Hepatol 2001; 13:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/15\">",
"      Pharoah PD, Guilford P, Caldas C, International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001; 121:1348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/16\">",
"      Oliveira C, Bordin MC, Grehan N, et al. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 2002; 19:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/17\">",
"      Humar B, Toro T, Graziano F, et al. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat 2002; 19:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/18\">",
"      Yabuta T, Shinmura K, Tani M, et al. E-cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer. Int J Cancer 2002; 101:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/19\">",
"      Jonsson BA, Bergh A, Stattin P, et al. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer. Int J Cancer 2002; 98:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/20\">",
"      Suriano G, Seixas S, Rocha J, Seruca R. A model to infer the pathogenic significance of CDH1 germline missense variants. J Mol Med (Berl) 2006; 84:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/21\">",
"      Suriano G, Oliveira C, Ferreira P, et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet 2003; 12:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/22\">",
"      Wang Y, Song JP, Ikeda M, et al. Ile-Leu substitution (I415L) in germline E-cadherin gene (CDH1) in Japanese familial gastric cancer. Jpn J Clin Oncol 2003; 33:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/23\">",
"      Charlton A, Blair V, Shaw D, et al. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004; 53:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/24\">",
"      Brooks-Wilson AR, Kaurah P, Suriano G, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004; 41:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/25\">",
"      Keller G, Vogelsang H, Becker I, et al. Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet 2004; 41:e89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/26\">",
"      Jiang Y, Wan YL, Wang ZJ, et al. [Germline E-cadherin gene mutation screening in familial gastric cancer kindreds]. Zhonghua Wai Ke Za Zhi 2004; 42:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/27\">",
"      Suriano G, Yew S, Ferreira P, et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 2005; 11:5401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/28\">",
"      Rodriguez-Sanjuan JC, Fontalba A, Mayorga M, et al. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain. Eur J Surg Oncol 2006; 32:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/29\">",
"      Frebourg T, Oliveira C, Hochain P, et al. Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer. J Med Genet 2006; 43:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/30\">",
"      Bacani JT, Soares M, Zwingerman R, et al. CDH1/E-cadherin germline mutations in early-onset gastric cancer. J Med Genet 2006; 43:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/31\">",
"      Roviello F, Corso G, Pedrazzani C, et al. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Eur J Surg Oncol 2007; 33:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/32\">",
"      More H, Humar B, Weber W, et al. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat 2007; 28:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/33\">",
"      Kaurah P, Fitzgerald R, Dwerryhouse S, Huntsman DG. Pregnancy after prophylactic total gastrectomy. Fam Cancer 2010; 9:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/34\">",
"      Van Domselaar F, Correa D, Vaccaro C, et al. [Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene]. Acta Gastroenterol Latinoam 2007; 37:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/35\">",
"      Caron O, Schielke A, Svrcek M, et al. Usefulness of prophylactic gastrectomy in a novel large hereditary diffuse gastric cancer (HDGC) family. Am J Gastroenterol 2008; 103:2160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/36\">",
"      Ghaffari SR, Dastan J, Rafati M, Sabokbar T. Novel human pathological mutations. Gene symbol: CDH1. Disease: gastric cancer. Hum Genet 2009; 125:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/37\">",
"      Ghaffari SR, Rafati M, Sabokbar T, Dastan J. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer. Eur J Surg Oncol 2010; 36:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/38\">",
"      Shah MA, Salo-Mullen E, Stadler Z, et al. De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer. Clin Genet 2012; 82:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/39\">",
"      Blair V, Martin I, Shaw D, et al. Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol 2006; 4:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/40\">",
"      Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/41\">",
"      Guilford P, Blair V, More H, Humar B. A short guide to hereditary diffuse gastric cancer. Hered Cancer Clin Pract 2007; 5:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/42\">",
"      Chun YS, Lindor NM, Smyrk TC, et al. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer 2001; 92:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/43\">",
"      Norton JA, Ham CM, Van Dam J, et al. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 2007; 245:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/44\">",
"      Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 2006; 14:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/45\">",
"      Park JG, Yang HK, Kim WH, et al. Report on the first meeting of the International Collaborative Group on Hereditary Gastric Cancer. J Natl Cancer Inst 2000; 92:1781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/46\">",
"      Lynch HT, Silva E, Wirtzfeld D, et al. Hereditary diffuse gastric cancer: prophylactic surgical oncology implications. Surg Clin North Am 2008; 88:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/47\">",
"      Masciari S, Larsson N, Senz J, et al. Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet 2007; 44:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/48\">",
"      Schrader KA, Masciari S, Boyd N, et al. Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer 2008; 7:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/49\">",
"      Xie ZM, Li LS, Laquet C, et al. Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer. Cancer 2011; 117:3112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/50\">",
"      Schrader KA, Masciari S, Boyd N, et al. Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. J Med Genet 2011; 48:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/51\">",
"      Oliveira C, Moreira H, Seruca R, et al. Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family. Virchows Arch 2005; 446:181.",
"     </a>",
"    </li>",
"    <li>",
"     Markman M. Principles of cancer screening. In: Cancer Screening: A Practical Guide for Physicians, Aziz K, Wu GY (Eds), Humana Press Inc, New Jersey 2002. p.3.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/53\">",
"      Hamy A, Letessier E, Bizouarn P, et al. Study of survival and prognostic factors in patients undergoing resection for gastric linitis plastica: a review of 86 cases. Int Surg 1999; 84:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/54\">",
"      Carneiro F, Huntsman DG, Smyrk TC, et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 2004; 203:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/55\">",
"      Barber ME, Save V, Carneiro F, et al. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. J Pathol 2008; 216:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/56\">",
"      Cisco RM, Ford JM, Norton JA. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer 2008; 113:1850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/57\">",
"      Barber M, Murrell A, Ito Y, et al. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol 2008; 216:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/58\">",
"      Hebbard PC, Macmillan A, Huntsman D, et al. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients. Ann Surg Oncol 2009; 16:1890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/59\">",
"      Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001; 344:1904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/60\">",
"      Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999; 36:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/61\">",
"      Rogers WM, Dobo E, Norton JA, et al. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Am J Surg Pathol 2008; 32:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/62\">",
"      Shaw D, Blair V, Framp A, et al. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut 2005; 54:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/63\">",
"      Chen Y, Kingham K, Ford JM, et al. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Ann Surg Oncol 2011; 18:2594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2296/abstract/64\">",
"      van Kouwen MC, Drenth JP, Oyen WJ, et al. [18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier. Clin Cancer Res 2004; 10:6456.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2511 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-109.230.63.219-37932DBF7B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2296=[""].join("\n");
var outline_f2_15_2296=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MOLECULAR GENETICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Risk of cancer in mutation carriers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Risk of other cancers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      IDENTIFICATION OF HIGH-RISK FAMILIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Genetic counseling and testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Criteria for genetic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1391653\">",
"      Expanded criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Performance of genetic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MANAGEMENT OF MUTATION CARRIERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Endoscopic assessment for gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Serial endoscopy with random biopsies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Chromoendoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PET scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Prophylactic gastrectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Screening for breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=related_link\">",
"      Characteristics of hereditary breast and ovarian cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15370?source=related_link\">",
"      Chromoendoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33194?source=related_link\">",
"      Pathology and molecular pathogenesis of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/34/3625?source=related_link\">",
"      Prophylactic total gastrectomy for hereditary diffuse gastric cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_15_2297="Acute sinusitis and rhinosinusitis in adults: Treatment";
var content_f2_15_2297=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute sinusitis and rhinosinusitis in adults: Treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/15/2297/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2297/contributors\">",
"     Peter H Hwang, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2297/contributors\">",
"     Anne Getz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/15/2297/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2297/contributors\">",
"     Daniel G Deschler, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2297/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/15/2297/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2297/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/15/2297/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H198762308\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute rhinosinusitis (ARS) is defined as symptomatic inflammation of the nasal cavity and paranasal sinuses lasting less than four weeks. The term \"rhinosinusitis\" is preferred to \"sinusitis\" since inflammation of the sinuses rarely occurs without concurrent inflammation of the nasal mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common etiology of ARS is a viral infection associated with the common cold. Viral rhinosinusitis is complicated by acute bacterial infection in only 0.5 to 2.0 percent of episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/2\">",
"     2",
"    </a>",
"    ]. Uncomplicated acute viral rhinosinusitis (AVRS) typically resolves in 7 to 10 days. Acute bacterial rhinosinusitis (ABRS) may also be a self-limited disease. Rarely, patients with untreated bacterial disease may develop serious complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link&amp;anchor=H11972301#H11972301\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\", section on 'Classification of rhinosinusitis'",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    Distinguishing AVRS related to colds and influenza-like illnesses from bacterial infection is a challenge frequently faced by the primary care clinician. Antibiotics are indicated for ABRS, but are ineffective and not recommended for AVRS. Despite the overwhelming prevalence of a viral etiology, however, in the late 1990s, 92 percent of patients in the United Kingdom [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/3\">",
"     3",
"    </a>",
"    ] and 85 to 98 percent of patients in the United States (US) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/4\">",
"     4",
"    </a>",
"    ] were prescribed an antibiotic when seen for an upper respiratory or sinus infection. Initiatives to limit the use of antibiotics for upper respiratory infections are ongoing in Europe and the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will address the treatment of acute rhinosinusitis. The clinical manifestations and diagnosis of acute rhinosinusitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H198762402\">",
"    <span class=\"h1\">",
"     APPROACH TO TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of treatment for acute rhinosinusitis (ARS) are different, depending on whether the source of infection is viral or bacterial. Management of acute viral rhinosinusitis (AVRS) aims to relieve symptoms of nasal obstruction and rhinorrhea; treatment does not shorten the clinical course of the disease. Treatment for acute bacterial rhinosinusitis (ABRS) includes antibiotics to eliminate the infection and prevent complications.",
"   </p>",
"   <p>",
"    Studies suggest that 40 to 69 percent of patients with ABRS may clear their infection spontaneously [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. In most of these studies, however, the diagnosis of acute bacterial infection was not confirmed by sinus aspirate culture, but rather was based upon clinical criteria. The populations studied were therefore likely to include patients with viral infection. Thus, the actual rate of spontaneous resolution of bacterial infection is not certain, but likely to be lower than the reported 40 to 60 percent.",
"   </p>",
"   <p>",
"    It is generally not possible to distinguish AVRS from ABRS in the first 10 days of illness based upon history, examination, or radiologic study. The diagnosis of ABRS is usually clinical, since sinus aspirates for culture are not readily obtainable. ABRS should be suspected in patients presenting with any of the following three features [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"    <br/>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent symptoms or signs of ARS lasting 10 or more days with no clinical improvement",
"     </li>",
"     <li>",
"      Onset with severe symptoms (fever &gt;39&deg;C or 102&deg;F and purulent nasal discharge or facial pain) lasting at least three consecutive days at the beginning of illness",
"     </li>",
"     <li>",
"      Onset with worsening symptoms following a viral upper respiratory infection that lasted five to six days and was initially improving",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link&amp;anchor=H98446144#H98446144\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\", section on 'Distinguishing bacterial from viral infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since AVRS is expected to resolve within 10 days and ABRS may also resolve spontaneously within the first 10 days, patients who present with fewer than 10 days of symptoms in general should be managed with supportive care [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/10\">",
"     10",
"    </a>",
"    ]. In a systematic review of 10 trials involving patients with uncomplicated acute sinusitis and a normal immune system, antibiotics slightly shortened the time to cure (number needed to treat for benefit 18) but increased the incidence of adverse effects (number needed to treat for harm 8) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11974577\">",
"    <span class=\"h1\">",
"     SYMPTOMATIC THERAPY FOR ACUTE RHINOSINUSITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute viral rhinosinusitis (AVRS) is a self-limited process and treatment is aimed at symptom relief. Acute bacterial rhinosinusitis (ABRS) should be treated with antibiotics, but adjunctive therapy for management of symptoms is also indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1205144\">",
"    <span class=\"h2\">",
"     Analgesics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Analgesics such as nonsteroidal antiinflammatories and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    are recommended for pain relief.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1205151\">",
"    <span class=\"h2\">",
"     Saline irrigation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical irrigation with buffered, physiologic, or hypertonic saline may reduce the need for pain medication and improve overall patient comfort, particularly in patients with frequent sinus infections [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/12\">",
"     12",
"    </a>",
"    ]. The evidence supporting use of saline irrigation is limited, but indicates some decrease in time lost from work and symptom relief with minor adverse effects, including nasal burning and irritation. It is important that irrigants be prepared from sterile or bottled water, as there have been reports of amebic encephalitis due to tap water rinses [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/13\">",
"     13",
"    </a>",
"    ]. Instructions for preparing a rinse solution are shown in a table (",
"    <a class=\"graphic graphic_table graphicRef71059 \" href=\"UTD.htm?42/33/43548\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1205158\">",
"    <span class=\"h2\">",
"     Topical glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The theoretic mechanism of action for intranasal glucocorticoids (corticosteroids) is a decrease in mucosal inflammation that allows improved sinus drainage. Studies evaluating topical glucocorticoids should be interpreted with caution, as many studies contain both heterogeneous patient populations (acute, chronic,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    viral rhinosinusitis) and different treatment regimens (concomitant decongestant, saline irrigation, antibiotic).",
"   </p>",
"   <p>",
"    Studies of topical glucocorticoids have demonstrated some benefit for the relief of symptoms in ARS, both viral and bacterial. A meta-analysis of three studies, involving patients with ARS diagnosed by symptoms and confirmed by radiologic or endoscopic studies, found that use of intranasal steroids, alone or as adjuvant therapy to antibiotics, increased the rate of symptom response compared to placebo (RR 1.11, 95% CI 1.04-1.18) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/14\">",
"     14",
"    </a>",
"    ]. Symptom resolution was greater for patients receiving intranasal glucocorticoids than placebo, and a dose response was observed, comparing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/15/36080?source=see_link\">",
"     mometasone",
"    </a>",
"    furoate 200 and 400 mcg. When used as an adjunct to antibiotic therapy in the treatment of ABRS, a meta-analysis of placebo-controlled trials suggests that 15 patients would need to be treated with intranasal glucocorticoids to improve clinical symptoms in one patient [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"     9",
"    </a>",
"    ]. One randomized study of patients with ABRS did not demonstrate benefit for intranasal glucocorticoids [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/15\">",
"     15",
"    </a>",
"    ]. Subgroup analysis of this study, however, found that patients with less-severe symptoms did benefit, possibly because thicker nasal secretions and closed ostia in patients with more severe illness limit penetrance of the topical steroids.",
"   </p>",
"   <p>",
"    Intranasal glucocorticoids are likely to be most beneficial for patients with underlying allergic rhinitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1205338\">",
"    <span class=\"h2\">",
"     Topical decongestants",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of topical decongestants, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/54/33632?source=see_link\">",
"     oxymetazoline",
"    </a>",
"    , may provide a subjective sense of improved nasal patency. However, there is some concern that topical decongestants themselves may provoke mucosal inflammation, at least in an experimental animal model [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/16\">",
"     16",
"    </a>",
"    ]. If used, topical decongestants should be used sparingly (no more than three consecutive days) to avoid rebound congestion [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/17\">",
"     17",
"    </a>",
"    ]. Topical decongestants are suggested for symptomatic relief in the treatment of AVRS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/18\">",
"     18",
"    </a>",
"    ]. However, they have little effect as adjunctive therapy to antibiotics in the treatment of ABRS, and 2012 guidelines advise that they are not helpful in patients with ABRS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1205165\">",
"    <span class=\"h2\">",
"     Oral decongestants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral decongestants are frequently used to reduce edema and facilitate aeration and drainage. Consistent reports on their efficacy are lacking, however. Some [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/19,20\">",
"     19,20",
"    </a>",
"    ], but not all [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/21\">",
"     21",
"    </a>",
"    ], studies have demonstrated improved patency of the nasal airway and sinus ostia. One randomized trial compared several oral decongestants (ephedrine sulfate 25 mg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19190?source=see_link\">",
"     pseudoephedrine",
"    </a>",
"    HCL 60 mg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/36/39488?source=see_link\">",
"     phenylephrine",
"    </a>",
"    HCL 10 mg, and phenylpropanolamine HCL 25 mg) with placebo; only ephedrine was superior to placebo in this trial [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/22\">",
"     22",
"    </a>",
"    ]. Similar to their recommendations against topical formulations, 2012 guidelines advise that oral decongestants are not helpful in patients with ABRS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"     9",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    When eustachian tube dysfunction is a significant confounding factor in AVRS, a short course (three to five days) of oral decongestants may be warranted. Oral decongestants should be used with caution in patients with cardiovascular disease, hypertension, or benign prostate hypertrophy due to systemic adverse effects with oral alpha adrenergic preparations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1205172\">",
"    <span class=\"h2\">",
"     Antihistamines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antihistamines are frequently prescribed for symptom relief due to their drying effects; however, there are no studies investigating their efficacy for this indication [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/18\">",
"     18",
"    </a>",
"    ]. Additionally, over-drying of the mucosa may lead to further discomfort. Antihistamines have side effects (drowsiness, xerostomia), and their use for the treatment of acute sinusitis is not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1205179\">",
"    <span class=\"h2\">",
"     Mucolytics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mucolytics such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16101?source=see_link\">",
"     guaifenesin",
"    </a>",
"    serve to thin secretions and may promote ease of mucus drainage and clearance; however, no published trials exist to definitively support their use [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11974584\">",
"    <span class=\"h1\">",
"     COMMUNITY-ACQUIRED ACUTE BACTERIAL RHINOSINUSITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who present with 10 or more days of symptoms (purulent rhinorrhea, nasal congestion, and facial pressure), the likelihood of a diagnosis of ABRS is increased. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link&amp;anchor=H98446144#H98446144\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\", section on 'Distinguishing bacterial from viral infection'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H198762402\">",
"     'Approach to treatment'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11974591\">",
"    <span class=\"h2\">",
"     Observation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who are diagnosed with ABRS should be treated with antimicrobial therapy. However, the diagnosis of a bacterial process is often uncertain, and watchful waiting with assurance of follow-up may be appropriate for some patients with milder symptoms. Guidelines from a multidisciplinary expert panel in 2007 recommend that selected patients with symptoms suggestive of mild ABRS (only mild pain and temperature &lt;38.3&deg;C or 101&deg;F) may be managed expectantly [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/18\">",
"     18",
"    </a>",
"    ]. Patients under observation should be treated supportively for relief of symptoms for seven days after the time of diagnosis. If there is no improvement over this interval, or if there is worsening at any time, antimicrobial therapy is then initiated. Guidelines from the Infectious Disease Society of America (IDSA) in 2012 recommend that antimicrobial therapy might be withheld for three days in patients with mild symptoms, but initiated promptly thereafter if there is no improvement [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"     9",
"    </a>",
"    ]. Factors such as age, general state of health, and comorbidities should be considered when choosing this option.",
"   </p>",
"   <p>",
"    Patients with moderately severe symptoms who meet clinical criteria for ABRS and patients with severe symptoms regardless of duration of illness should be treated with an antibiotic. Guidelines from the IDSA in 2012 recommend initiation of antibiotic therapy when ABRS is diagnosed by standardized criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"     9",
"    </a>",
"    ]. The rationale is to shorten the duration of illness, relieve symptoms, and prevent recurrent infection or complications. An algorithm for the treatment of acute bacterial rhinosinusitis is shown (",
"    <a class=\"graphic graphic_algorithm graphicRef83208 \" href=\"UTD.htm?15/54/16224\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H11974598\">",
"     'Antimicrobials'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11974598\">",
"    <span class=\"h2\">",
"     Antimicrobials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies and meta-analyses have addressed the efficacy of systemic antibiotics in the treatment of acute rhinosinusitis (ARS). Given the difficulty in distinguishing viral from bacterial infection, these studies are complicated by heterogeneity in patient symptoms, underlying etiology, and outcomes of treatment.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized trial of adult patients (n = 166) presenting to primary care offices who met clinical criteria for acute bacterial rhinosinusitis (ABRS) evaluated whether a 10-day course of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      , compared to placebo, improved disease-related quality of life as measured by a symptom score [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/24\">",
"       24",
"      </a>",
"      ]. There was no difference between groups at day 3, the primary specified outcome, or at day 10, although there was greater symptom improvement reported by the amoxicillin group at day 7. All patients were also offered symptomatic treatment for relief of pain, fever, cough, and nasal congestion. &nbsp;",
"     </li>",
"     <li>",
"      A 2008 meta-analysis based upon individual patient data (n = 2547) from nine randomized trials found that 15 patients with rhinosinusitis would need to be treated with antibiotics before one additional patient would be cured [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/25\">",
"       25",
"      </a>",
"      ]. Clinical signs and symptoms did not define a patient subgroup that was more likely to benefit from treatment or distinguish viral from bacterial infection.",
"     </li>",
"     <li>",
"      A 2012 meta-analysis of 13 randomized trials in adults with ABRS (n = 2878) found that 13 patients (95% CI 9-22) would need to be treated with antibiotics for one to benefit [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A 2008 meta-analysis pooled results from 17 randomized trials in which acute sinusitis was variably diagnosed (the majority by clinical criteria, but also imaging, microbiology, and inflammatory markers) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/7\">",
"       7",
"      </a>",
"      ]. There was variability in choice of antibiotic, use of ancillary therapy, and inclusion of children (three studies). Compared to placebo, antibiotics were associated with a higher rate of cure or symptom improvement at 7 to 15 days (OR 1.64, 95% CI 1.35-2.0), but the magnitude of effect was moderate (cure or improvement in 77 percent with antibiotics versus 68 percent with placebo). The 9 percent difference in",
"      <span class=\"nowrap\">",
"       cure/improvement",
"      </span>",
"      rate with antibiotic therapy was at the expense of an 8 percent increase in adverse effects, mostly gastrointestinal (30 versus 22 percent for placebo-treated patients).",
"     </li>",
"     <li>",
"      A meta-analysis that analyzed data from five trials comparing antibiotics to placebo, defining failure as lack of cure or improvement at 7 to 15 days follow-up, found an increased response rate for antibiotics (RR 0.66, 95% CI 0.44-0.98) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/26\">",
"       26",
"      </a>",
"      ]. Eighty percent of the participants not treated with antibiotics and 90 percent of the antibiotic group improved within two weeks. No one antibiotic was superior to another in the review of 51 studies comparing antibiotics.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H198762701\">",
"    <span class=\"h3\">",
"     Choice of antibiotic",
"    </span>",
"    &nbsp;&mdash;&nbsp;When antibiotics are administered, treatment is most often initiated empirically. Although culture-guided therapy is optimal, obtaining suitable cultures requires endoscopy or antral puncture and is generally reserved for patients with complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link&amp;anchor=H9#H9\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\", section on 'Diagnostic tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most comparative studies of antibiotics for the treatment of ABRS do not involve patients with culture-defined infection and therefore include patients who meet predefined clinical criteria but who may not have bacterial infection. The significant rate of spontaneous recovery in mixed populations of AVRS and ABRS decreases the ability of studies to differentiate between less-effective and more-effective antibiotics (the apparent response to less-effective antibiotics is greater than would be seen in a more strictly defined ABRS population; conversely, the relative effectiveness of more appropriate antibiotics is diminished). Thus, the finding in multiple studies of equivalent effectiveness among antibiotics is called into some question [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/8,26-30\">",
"     8,26-30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"     Amoxicillin",
"    </a>",
"    has been recommended as a first-line agent in the past because of its narrow spectrum and relative low cost. However, there is increasing emergence of antimicrobial resistance among respiratory pathogens, including pneumococci and H. influenzae. Resistance rates vary regionally, with the prevalence of H. influenzae resistance ranging from 27 to 43 percent in the US [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"     9",
"    </a>",
"    ]. Additionally, the introduction of routine conjugated pneumococcal vaccination in children has changed the spectrum of bacterial infection. In both adults and children, the percentage of ABRS due to S. pneumoniae has decreased while the proportion of ABRS due to H. influenzae has increased.",
"   </p>",
"   <p>",
"    The addition of clavulanate to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    improves coverage for ampicillin-resistant H. influenzae as well as M. catarrhalis. While evidence is stronger in children than adults to support use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    instead of amoxicillin, the IDSA 2012 guidelines makes the following recommendations regarding antimicrobial treatment of ABRS in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"       Amoxicillin-clavulanate",
"      </a>",
"      rather than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      is recommended as empiric therapy for non-penicillin allergic adults. Amoxicillin-clavulanate is also preferred to a respiratory fluoroquinolone as initial empiric therapy. The dose of amoxicillin-clavulanate for most patients would be either 500",
"      <span class=\"nowrap\">",
"       mg/125",
"      </span>",
"      mg orally three times daily or 875",
"      <span class=\"nowrap\">",
"       mg/125",
"      </span>",
"      mg orally twice daily.",
"     </li>",
"     <li>",
"      High-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"       amoxicillin-clavulanate",
"      </a>",
"      (2 g orally twice daily) is recommended in geographic regions with rates of penicillin-nonsusceptible S. pneumonia exceeding 10 percent and for patients who meet any of the following criteria: 65 years and older, recently hospitalized, treated with an antibiotic in the previous month, or immunocompromised.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       Doxycycline",
"      </a>",
"      is a reasonable alternative for first-line therapy and can be used in patients with penicillin allergy. A respiratory fluoroquinolone (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"       moxifloxacin",
"      </a>",
"      ) is another option for penicillin-allergic patients.",
"     </li>",
"     <li>",
"      Macrolides (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/57/10138?source=see_link\">",
"       clarithromycin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      ),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      , and second- or third-generation cephalosporins are",
"      <strong>",
"       not",
"      </strong>",
"      recommended for empiric therapy because of high rates of resistance of S. pneumoniae (and of H. influenzae for trimethoprim-sulfamethoxazole).",
"     </li>",
"     <li>",
"      Routine coverage for S. aureus or methicillin-resistant S. aureus (MRSA) is not indicated at this time. Despite the prevalence of staphylococcal colonization in the middle meatus in health adults, S. aureus remains an uncommon cause of ABRS [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Local and regional histograms of bacterial resistance should be referenced to understand resistance trends in the local community.",
"   </p>",
"   <p>",
"    The recommendation to treat with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    rather than a respiratory fluoroquinolone is based upon studies showing equivalent effectiveness in patients with culture-documented infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/32\">",
"     32",
"    </a>",
"    ] and a need to limit the overuse of fluoroquinolones in an effort to slow the development of resistance to this antibiotic class.",
"   </p>",
"   <p>",
"    Pregnant patients can be treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    (class B); pregnant patients who are penicillin-allergic would need to be treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    (class B), as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    (class D) and fluoroquinolones (class C) are not options in pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2023275\">",
"    <span class=\"h3\">",
"     Duration for initial treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The IDSA guidelines advise a 5 to 7 day course of antibiotics (rather than 10 to 14 days) in adults. In one meta-analysis of 12 randomized trials of ABRS in adults, no difference was noted in response rates or relapse rates comparing short courses (3 to 7 days) and longer courses (6 to 10 days) of antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/33\">",
"     33",
"    </a>",
"    ]. Rates of adverse events were lower for 5 day compared with 10 day courses. However, there was heterogeneity in the trials in terms of symptom duration and use of adjunctive medications. Studies of antimicrobial response, based upon sinus aspirate cultures in children, indicate bacterial eradication within 72 hours for appropriate antimicrobial treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/34\">",
"     34",
"    </a>",
"    ], supporting a shorter antibiotic course than has traditionally been advised. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1205456\">",
"    <span class=\"h2\">",
"     Systemic glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review and meta-analysis of four randomized trials in adults with acute sinusitis (n = 1008) found that systemic glucocorticoids plus antibiotic, compared with antibiotic plus placebo or, in one trial, a nonsteroidal anti-inflammatory, resulted in improved symptom control at days three to seven (risk ratio, RR 1.4, 95% CI 1.1-1.8) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/35\">",
"     35",
"    </a>",
"    ]. Radiologic findings consistent with acute sinusitis were part of the diagnostic criteria in three studies. These data are limited by the potential for attrition bias and the lack of long-term follow-up on the effects of steroids. In a subsequent randomized trial, oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    30 mg daily for seven days was not more effective than placebo in reducing facial pain or pressure on day seven for adult patients with clinically diagnosed acute rhinosinusitis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unlike topical glucocorticoids, systemic glucocorticoids possess a significant side effect profile, including hyperglycemia, hypertension, increased appetite, mood changes, and insomnia, as well as effects on bone metabolism and cataract formation with more chronic exposure. We suggest not using systemic glucocorticoids in the outpatient treatment of acute rhinosinusitis pending the availability of additional data from higher-quality trials. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11974626\">",
"    <span class=\"h2\">",
"     Treatment failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with ABRS are expected to show some response to empiric antimicrobial therapy after three to five days. An alternative treatment strategy is indicated for patients with ABRS who fail to show some improvement in that time frame, or in whom symptoms worsen after at least two to three days of therapy. Experimental evidence indicates bacterial eradication by day three [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/37,38\">",
"     37,38",
"    </a>",
"    ] and studies have correlated clinical and bacteriologic response [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/39\">",
"     39",
"    </a>",
"    ]. Although older adults or those with multiple morbidities may take longer to resolve infection, such individuals should also show some symptom improvement within five days of initiating antimicrobial therapy for ABRS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reasons for treatment failure include resistant pathogens, inadequate dosing, structural abnormalities, or a noninfectious etiology. Patients who fail first-line therapy require alternative antibiotic selection. Ideally, an endoscopically-guided culture could be performed to redirect antibiotic therapy, although this is often impractical. Options for second-line therapy provide a broader spectrum of activity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a different class of agent.",
"   </p>",
"   <p>",
"    Guidelines from the IDSA recommend the following options for empiric second-line treatment. If improvement is seen within 3 to 5 days of initiation of therapy, a total course duration of 7 to 10 days is recommended:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"       Amoxicillin-clavulanate",
"      </a>",
"      2000",
"      <span class=\"nowrap\">",
"       mg/125",
"      </span>",
"      mg orally twice daily",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       Levofloxacin",
"      </a>",
"      500 mg orally once daily",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"       Moxifloxacin",
"      </a>",
"      400 mg orally once daily",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with severe infection requiring hospitalization could be treated with one of the following: a respiratory fluoroquinolone (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    in doses above, either orally or intravenously) or intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1160?source=see_link\">",
"     ampicillin-sulbactam",
"    </a>",
"    1.5 to 3.0 g every six hours,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    1 to 2 g every 24 hours, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"     cefotaxime",
"    </a>",
"    2 g every four to six hours. Although specific recommendations from the IDSA are not available, we suggest that intravenous antibiotics be given until there is clear evidence of patient response, at which time the patient could be discharged on an oral antibiotic with similar activity to complete a 10-day course. If there is no response to intravenous antibiotics within 48 hours of hospitalization, a CT scan should be performed to verify the diagnosis and to evaluate for suppurative complications (eg, orbital cellulitis, intracranial abscess) and an ENT consultation requested to obtain sinus cultures and for consideration of the need for surgical intervention.",
"   </p>",
"   <p>",
"    A CT scan of the sinuses is indicated if symptoms worsen or fail to improve. For patients who have failed to respond to both first- and second-line therapy, sinus cultures should be obtained either by direct aspirate or endoscopy of the middle meatus; nasopharyngeal cultures are not reliable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11974633\">",
"    <span class=\"h2\">",
"     Relapse after treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrence of symptoms within two weeks of response to initial treatment usually represents inadequate eradication of infection. Patients who had a good response to initial therapy and who have mild symptoms of relapse can be treated with a longer course of the same antibiotic. Patients who had only minimal symptom response with the initial antibiotic or whose relapse is moderate to severe, however, are more likely to have organisms resistant to the initial empiric antibiotic and would require a change in the drug selected. The recommended duration of antibiotic treatment for relapse has not been addressed by published guidelines. The treatment duration should be guided by the goal of full resolution of symptoms. If symptoms persist despite a repeat 7- to 10-day course of antibiotics, referral to an otolaryngologist is warranted.",
"   </p>",
"   <p>",
"    Patients who had only minimal symptom response with the initial antibiotic or whose relapse is moderate to severe, however, are more likely to have organisms resistant to the initial empiric antibiotic and would require a change in the drug selected. (See",
"    <a class=\"local\" href=\"#H11974626\">",
"     'Treatment failure'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2085402\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR SPECIALTY REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early referral is essential for patients whose symptoms indicate the need for urgent endoscopy or surgical biopsy, or for diagnostic testing (imaging or immunologic testing) that couldn&rsquo;t be performed where they have initially presented. Such patients include those with severe infection (high persistent fever, orbital edema, severe headache, visual disturbance, altered mental status, or meningeal signs), those in whom fungal sinusitis or granulomatous disease is suspected, and those with nosocomial infection.",
"   </p>",
"   <p>",
"    Patients with identified anatomic defects causing obstruction require referral for surgery. Patients who are immunocompromised or are found to have unusual or resistant pathogens might benefit from consultation with an infectious disease specialist. Additionally, referral is indicated for patients with ABRS who have failed to respond to first- and second-line antimicrobial therapy.",
"   </p>",
"   <p>",
"    The 2012 IDSA guidelines have developed consensus recommendations about indications for less-urgent specialty referral as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Multiple recurrent episodes of ABRS (three to four episodes per year)",
"     </li>",
"     <li>",
"      Chronic rhinosinusitis (with or without polyps or asthma) with recurrent exacerbations of ABRS",
"     </li>",
"     <li>",
"      Patients with allergic rhinitis who may be candidates for immunotherapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11974640\">",
"    <span class=\"h1\">",
"     SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no indication for surgery in patients with uncomplicated ABRS. However, surgery may be emergently indicated in patients experiencing extra-sinus complications of ABRS, including orbital abscess, epidural abscess, meningitis, and brain abscess. Surgical debridement is also indicated for the treatment of acute invasive fungal rhinosinusitis, a condition for which mortality rates remain high despite timely debridement and systemic antifungal therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8775?source=see_link\">",
"     \"Fungal rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indications for surgery in patients with chronic rhinosinusitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/4/30794?source=see_link&amp;anchor=H32#H32\">",
"     \"Management of chronic rhinosinusitis\", section on 'Indications for surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/53/17234?source=see_link\">",
"       \"Patient information: Sinusitis in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/12/12483?source=see_link\">",
"       \"Patient information: What you should know about antibiotics (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/13/37073?source=see_link\">",
"       \"Patient information: Acute sinusitis (sinus infection) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11976252\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is generally not possible to distinguish viral from bacterial acute rhinosinusitis (ARS) in the first 10 days of illness. Acute bacterial rhinosinusitis (ABRS) should be suspected in patients presenting with any of the following three features: 1) persistent symptoms or signs of ARS lasting 10 or more days with no clinical improvement; 2) onset with severe symptoms (fever &gt;39&deg;C or 102&deg;F and purulent nasal discharge or facial pain) lasting at least three consecutive days at the beginning of illness; 3) onset with worsening symptoms following a viral upper respiratory infection that lasted five to six days and was initially improving. Management of acute viral rhinosinusitis (AVRS) aims to relieve symptoms of nasal obstruction and rhinorrhea; treatment for ABRS includes antibiotics to eliminate the infection and prevent complications. (See",
"      <a class=\"local\" href=\"#H198762402\">",
"       'Approach to treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      AVRS is expected to resolve within 10 days; ABRS may also resolve spontaneously within the first 10 days. Patients who present with fewer than 10 days of symptoms, in the absence of high fever or symptoms suggesting complicated illness, should be managed with supportive care. We suggest mild analgesics, saline nasal irrigation, and fluid (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We suggest treatment with intranasal glucocorticoids (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Decongestants may be useful when eustachian tube dysfunction is a factor for patients with AVRS, but are not likely to be helpful for patients with ABRS and have adverse side effects. We suggest not treating symptoms with antihistamines (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11974577\">",
"       'Symptomatic therapy for acute rhinosinusitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend treatment with an antibiotic for patients whose clinical symptoms meet criteria for ABRS (",
"      <a class=\"graphic graphic_algorithm graphicRef83208 \" href=\"UTD.htm?15/54/16224\">",
"       algorithm 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). In light of increasing microbial resistance to antibiotics, we suggest initial empiric treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"       amoxicillin-clavulanate",
"      </a>",
"      rather than macrolides (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/57/10138?source=see_link\">",
"       clarithromycin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      ),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      , or oral second- or third-generation cephalosporins (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). For most patients,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      -clavulanate (either 500",
"      <span class=\"nowrap\">",
"       mg/125",
"      </span>",
"      mg orally three times daily or 875",
"      <span class=\"nowrap\">",
"       mg/125",
"      </span>",
"      mg orally twice daily) should be given for five to seven days.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       Doxycycline",
"      </a>",
"      is a reasonable alternative for first-line therapy and can be used in patients with penicillin allergy. A respiratory fluoroquinolone (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"       moxifloxacin",
"      </a>",
"      ) is another option for penicillin-allergic patients. (See",
"      <a class=\"local\" href=\"#H198762701\">",
"       'Choice of antibiotic'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2023275\">",
"       'Duration for initial treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Local and regional histograms of bacterial resistance should be referenced to understand resistance trends in the local community. (See",
"      <a class=\"local\" href=\"#H198762701\">",
"       'Choice of antibiotic'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients with ABRS are expected to show some response to empiric antimicrobial therapy after three to five days. An alternative treatment strategy is indicated for patients with ABRS who fail to show some improvement in that time frame, or in whom symptoms worsen after at least two to three days of therapy. Options for second-line empiric therapy include high-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"       amoxicillin-clavulanate",
"      </a>",
"      (2000",
"      <span class=\"nowrap\">",
"       mg/125",
"      </span>",
"      mg orally twice daily) or a respiratory fluoroquinolone (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      500 mg orally once daily or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"       moxifloxacin",
"      </a>",
"      400 mg orally once daily). (See",
"      <a class=\"local\" href=\"#H11974626\">",
"       'Treatment failure'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specialty referral on an urgent basis is indicated for patients with severe infection (high persistent fever, orbital edema, severe headache, visual disturbance, altered mental status, or meningeal signs), those in whom fungal sinusitis or granulomatous disease is suspected, and those with nosocomial infection. Referral is also indicated for patients with obstructive anatomic defects, immunocompromise, resistant pathogens, or failure to respond to first- and second-line antimicrobial therapy. (See",
"      <a class=\"local\" href=\"#H2085402\">",
"       'Indications for specialty referral'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      There is no indication for surgery in patients with uncomplicated ABRS. However, surgery may be emergently indicated in patients experiencing extra-sinus complications of ABRS, including orbital abscess, epidural abscess, meningitis, and brain abscess. (See",
"      <a class=\"local\" href=\"#H11974640\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/1\">",
"      Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004; 131:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/2\">",
"      Fokkens W, Lund V, Mullol J, European Position Paper on Rhinosinusitis and Nasal Polyps Group. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 2007; 45:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/3\">",
"      Ashworth M, Charlton J, Ballard K, et al. Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995-2000. Br J Gen Pract 2005; 55:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/4\">",
"      Hickner JM, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 134:498.",
"     </a>",
"    </li>",
"    <li>",
"     Get Smart: Know when antibioitcs work. Centers for Disease Control and Prevention. file://www.cdc.gov/getsmart/resources/related-programs.html (Accessed on March 27, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/6\">",
"      Hwang PH. A 51-year-old woman with acute onset of facial pressure, rhinorrhea, and tooth pain: review of acute rhinosinusitis. JAMA 2009; 301:1798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/7\">",
"      Falagas ME, Giannopoulou KP, Vardakas KZ, et al. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials. Lancet Infect Dis 2008; 8:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/8\">",
"      de Ferranti SD, Ioannidis JP, Lau J, et al. Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ 1998; 317:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/9\">",
"      Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 2012; 54:e72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/10\">",
"      Tan T, Little P, Stokes T, Guideline Development Group. Antibiotic prescribing for self limiting respiratory tract infections in primary care: summary of NICE guidance. BMJ 2008; 337:a437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/11\">",
"      Lemiengre MB, van Driel ML, Merenstein D, et al. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database Syst Rev 2012; 10:CD006089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/12\">",
"      Kassel JC, King D, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev 2010; :CD006821.",
"     </a>",
"    </li>",
"    <li>",
"     Louisiana Department of Health and Hospitals. file://new.dhh.louisiana.gov/index.cfm/newsroom/detail/2332 (Accessed on January 22, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/14\">",
"      Zalmanovici A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev 2009; :CD005149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/15\">",
"      Williamson IG, Rumsby K, Benge S, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA 2007; 298:2487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/16\">",
"      Bende M, Fukami M, Arfors KE, et al. Effect of oxymetazoline nose drops on acute sinusitis in the rabbit. Ann Otol Rhinol Laryngol 1996; 105:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/17\">",
"      Spector SL, Bernstein IL, Li JT, et al. Parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol 1998; 102:S107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/18\">",
"      Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007; 137:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/19\">",
"      Roth RP, Cantekin EI, Bluestone CD, et al. Nasal decongestant activity of pseudoephedrine. Ann Otol Rhinol Laryngol 1977; 86:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/20\">",
"      Mel&eacute;n I, Friberg B, Andr&eacute;asson L, et al. Effects of phenylpropanolamine on ostial and nasal patency in patients treated for chronic maxillary sinusitis. Acta Otolaryngol 1986; 101:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/21\">",
"      Aust R, Drettner B, Falck B. Studies of the effect of peroral fenylpropanolamin on the functional size of the human maxillary ostium. Acta Otolaryngol 1979; 88:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/22\">",
"      MCLAURIN JW, SHIPMAN WF, ROSEDALE R Jr. Oral decongestants. A double blind comparison study of the effectiveness of four sympathomimetic drugs: objective and subjective. Laryngoscope 1961; 71:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/23\">",
"      Ziment I. Management of respiratory problems in the aged. J Am Geriatr Soc 1982; 30:S36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/24\">",
"      Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA 2012; 307:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/25\">",
"      Young J, De Sutter A, Merenstein D, et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet 2008; 371:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/26\">",
"      Ahovuo-Saloranta A, Borisenko OV, Kovanen N, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2008; :CD000243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/27\">",
"      de Bock GH, Dekker FW, Stolk J, et al. Antimicrobial treatment in acute maxillary sinusitis: a meta-analysis. J Clin Epidemiol 1997; 50:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/28\">",
"      Karageorgopoulos DE, Giannopoulou KP, Grammatikos AP, et al. Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ 2008; 178:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/29\">",
"      Piccirillo JF, Mager DE, Frisse ME, et al. Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis. JAMA 2001; 286:1849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/30\">",
"      Anon JB, Jacobs MR, Poole MD, et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004; 130:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/31\">",
"      Wald ER. Staphylococcus aureus: is it a pathogen of acute bacterial sinusitis in children and adults? Clin Infect Dis 2012; 54:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/32\">",
"      Arrieta JR, Galgano AS, Sakano E, et al. Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis. Am J Otolaryngol 2007; 28:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/33\">",
"      Falagas ME, Karageorgopoulos DE, Grammatikos AP, Matthaiou DK. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials. Br J Clin Pharmacol 2009; 67:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/34\">",
"      Wald ER, Chiponis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infections in children: a double-blind, placebo-controlled trial. Pediatrics 1986; 77:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/35\">",
"      Venekamp RP, Thompson MJ, Hayward G, et al. Systemic corticosteroids for acute sinusitis. Cochrane Database Syst Rev 2011; :CD008115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/36\">",
"      Venekamp RP, Bonten MJ, Rovers MM, et al. Systemic corticosteroid monotherapy for clinically diagnosed acute rhinosinusitis: a randomized controlled trial. CMAJ 2012; 184:E751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/37\">",
"      Ariza H, Rojas R, Johnson P, et al. Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis. BMC Ear Nose Throat Disord 2006; 6:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/38\">",
"      Anon JB, Paglia M, Xiang J, et al. Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis. Diagn Microbiol Infect Dis 2007; 57:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2297/abstract/39\">",
"      Ambrose PG, Anon JB, Owen JS, et al. Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis. Clin Infect Dis 2004; 38:1513.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 83012 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-199.231.185.123-B6CE745EC8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2297=[""].join("\n");
var outline_f2_15_2297=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11976252\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H198762308\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H198762402\">",
"      APPROACH TO TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11974577\">",
"      SYMPTOMATIC THERAPY FOR ACUTE RHINOSINUSITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1205144\">",
"      Analgesics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1205151\">",
"      Saline irrigation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1205158\">",
"      Topical glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1205338\">",
"      Topical decongestants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1205165\">",
"      Oral decongestants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1205172\">",
"      Antihistamines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1205179\">",
"      Mucolytics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11974584\">",
"      COMMUNITY-ACQUIRED ACUTE BACTERIAL RHINOSINUSITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11974591\">",
"      Observation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11974598\">",
"      Antimicrobials",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H198762701\">",
"      - Choice of antibiotic",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2023275\">",
"      - Duration for initial treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1205456\">",
"      Systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11974626\">",
"      Treatment failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11974633\">",
"      Relapse after treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2085402\">",
"      INDICATIONS FOR SPECIALTY REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11974640\">",
"      SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11976252\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/83012\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/83012|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?15/54/16224\" title=\"algorithm 1\">",
"      Mgmt algorithm ABRS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/83012|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/33/43548\" title=\"table 1\">",
"      Nasal irrigation instruct",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=related_link\">",
"      Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8775?source=related_link\">",
"      Fungal rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/4/30794?source=related_link\">",
"      Management of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/13/37073?source=related_link\">",
"      Patient information: Acute sinusitis (sinus infection) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/53/17234?source=related_link\">",
"      Patient information: Sinusitis in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/12/12483?source=related_link\">",
"      Patient information: What you should know about antibiotics (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_15_2298="Virus-induced wheezing and asthma: An overview";
var content_f2_15_2298=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Virus-induced wheezing and asthma: An overview",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/15/2298/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2298/contributors\">",
"     Sujani Kakumanu, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/15/2298/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2298/contributors\">",
"     Gregory Redding, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2298/contributors\">",
"     Robert A Wood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/15/2298/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/15/2298/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/15/2298/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral respiratory infections, particularly with respiratory syncytial virus (RSV) and human rhinovirus (HRV), are the most common causes of wheezing in infants and young children and are common triggers of asthma exacerbations in patients with preexisting asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. In addition, wheezing with viral illnesses in infants and young children is associated with an increased risk of childhood asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/5-10\">",
"     5-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanisms by which viral respiratory infections trigger wheezing and asthma exacerbations are reviewed here. The influence of viral infection on both the development and perpetuation of asthma is also discussed. Other issues relating to the pathogenesis of asthma are reviewed elsewhere. Treatment of virus-induced wheezing and asthma is also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4937?source=see_link\">",
"     \"Pathogenesis of asthma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=see_link\">",
"     \"Risk factors for asthma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7383?source=see_link\">",
"     \"Natural history of asthma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/44/22216?source=see_link\">",
"     \"Treatment of recurrent virus-induced wheezing in young children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral respiratory infections interact with host factors to promote virus-induced wheezing and asthma exacerbations (",
"    <a class=\"graphic graphic_figure graphicRef58691 \" href=\"UTD.htm?18/33/18974\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/11\">",
"     11",
"    </a>",
"    ]. Respiratory symptoms with viral infections probably result from virus-induced damage of the airway epithelium, followed by airway inflammation in a predisposed individual. Immune responses triggered by viral respiratory tract infections include enhanced allergic inflammation, increased granulocyte recruitment, promotion of cytokine production, and upregulation of the parasympathetic response (",
"    <a class=\"graphic graphic_table graphicRef75402 \" href=\"UTD.htm?14/22/14700\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Epithelial Cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory epithelial cells are the initial site of viral inoculation and serve as the primary site of viral replication. Respiratory viruses, such as influenza and RSV cause cytopathic damage to airway epithelium and these changes can affect the function of the epithelium and airway smooth muscle. In addition, disturbing the integrity of the epithelial layer may enhance mucosal permeability and increase exposure of inflammatory and antigen presenting cells to allergens.",
"   </p>",
"   <p>",
"    About 90 percent of rhinovirus HRV-A and HRV-B serotypes bind to respiratory epithelial cells via the intercellular adhesion molecule 1 (ICAM-1), while a minority, belonging to the HRV-A group, bind to the very low density lipoprotein (VLDL) receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. The receptor for HRV-C strains has not yet been identified. Rhinoviruses, in contrast to other respiratory viruses, do not damage the epithelium. However, rhinovirus and other respiratory viruses can activate epithelial cells to upregulate the expression of ICAM-1 receptors, enhancing replication of HRV. They also induce epithelial cells to secrete a wide variety of chemokines and cytokines, including interleukin (IL)-6, IL-8 (CXCL8), IL-11, and RANTES (CCL5), a chemoattractant for eosinophils, monocytes, and T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/14-20\">",
"     14-20",
"    </a>",
"    ]. Many of these mediators have been identified in experimental or natural infections, and can affect cell recruitment, cell activation, and the overall inflammatory response. Furthermore, in vitro work showing upregulation of MHC class I and costimulatory molecules B7-1 and B7-2 in pulmonary epithelial cells after rhinovirus infection suggests that epithelial cells may play a role in antigen presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Airway inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory viral infection and replication activate innate and adaptive antiviral immune responses, resulting in proinflammatory cytokine and chemokine production and the recruitment of inflammatory cells to the airway. Rhinovirus has shown few cytopathic effects on airway epithelium or other tissues in contrast to other respiratory viruses, such as RSV and influenza [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. These observations raise the possibility that rhinovirus can induce and promote airway inflammation by its interaction with airway cells and the subsequent stimulation of cytokine production.",
"   </p>",
"   <p>",
"    Rhinovirus infection was experimentally induced in a number of studies and the subsequent response to antigen challenge was evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/25-30\">",
"     25-30",
"    </a>",
"    ]. Experimental infections with rhinovirus lead to increased airway responsiveness, enhanced inflammatory responses, a higher likelihood for the development of the late allergic reaction, and eosinophil recruitment to the airway following antigen challenge. The histologic changes seen with experimental infection are also seen in biopsies from individuals with naturally-occurring rhinovirus colds. Collectively, these studies support the view that rhinovirus promotes lower airway inflammation to allergen, and can thereby enhance existing allergic inflammation. The following studies are illustrative:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two studies found increased airway responsiveness to histamine and augmentation of both the immediate and late phase responses to inhaled allergen following experimental rhinovirus infection in patients with allergic rhinitis (",
"      <a class=\"graphic graphic_figure graphicRef79253 \" href=\"UTD.htm?24/41/25247\">",
"       figure 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. In one of these reports, rhinovirus infection enhanced the allergic inflammatory reaction in the lower airway, as demonstrated by increased recruitment of eosinophils to the airway following segmental antigen challenge [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased submucosal lymphocytes and epithelial eosinophils are demonstrated on biopsy of the lower airway during rhinovirus colds that are associated with increased airway responsiveness to histamine [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/28\">",
"       28",
"      </a>",
"      ]. The increase in mucosal eosinophils persists well into the convalescent period in subjects with asthma. In another study, nasal lavage eosinophil counts prior to experimental rhinovirus infection were inversely correlated with the severity and duration of subsequent cold symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Studies have also shown that rhinovirus replicates equally well in the upper and lower airways [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/29\">",
"       29",
"      </a>",
"      ]. In these studies, bronchial epithelial cells from patients with asthma show markedly increased rhinovirus replication compared with those without asthma. In addition, rhinovirus can enter the lower airway and stimulate",
"      <span class=\"nowrap\">",
"       monocytes/macrophages",
"      </span>",
"      and lymphocytes [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/29\">",
"       29",
"      </a>",
"      ]. This interaction can lead to the recruitment of inflammatory cells to the airway and generation of proinflammatory and antiviral mediators.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Granulocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutrophils are the principal cells recruited to the airways during the acute phase of a viral infection and are also recruited to the lower airways during experimental rhinovirus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/31\">",
"     31",
"    </a>",
"    ]. During acute viral illness, HRV infected adults with asthma have increased recruitment of neutrophils compared with HRV infected adults without asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/32\">",
"     32",
"    </a>",
"    ]. This response is, in part, regulated by IL-8 (CXCL8) and leukotriene B4 (LTB4) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/14,33-37\">",
"     14,33-37",
"    </a>",
"    ]. There is evidence that the recruited cells are activated; levels of airway granulocyte enzymes (eg, myeloperoxidase) increase in parallel with the recruitment of neutrophils. The mechanism by which these cells are activated during the viral illness is not well understood.",
"   </p>",
"   <p>",
"    The interrelationship between eosinophils and viral infections is less well defined [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/38-41\">",
"     38-41",
"    </a>",
"    ]. There is little evidence from in vitro studies that rhinoviruses activate eosinophils, in contrast to in vivo observations. Eosinophils are increased in the bronchial epithelium in biopsies of both patients with asthma and controls during acute rhinovirus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/28\">",
"     28",
"    </a>",
"    ]. Increased levels of LTC4 are seen in nasal secretions of children with wheezing during RSV infections [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/41\">",
"     41",
"    </a>",
"    ]. This finding suggests that eosinophil recruitment to the airway and activation events may be directly related to RSV actions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Macrophages and monocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway macrophages are the predominant airway cell and are probably involved in host responses to respiratory viruses. Nasal secretions obtained during upper respiratory tract infections contain IL-1, tumor necrosis factor (TNF)-alpha, and IL-8 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/34,35,42,43\">",
"     34,35,42,43",
"    </a>",
"    ]. A similar cytokine pattern is seen when macrophages are incubated with respiratory viruses in vitro [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/14,44-46\">",
"     14,44-46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These cytokines are important in the development of acute symptoms, such as fever and myalgia. In addition, these mediators can stimulate epithelial cells to express adhesion molecules, such as intercellular adhesion molecule (ICAM)-1 (CD54) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/45\">",
"     45",
"    </a>",
"    ]. This upregulation of adhesion molecule expression can have a dual effect of increasing both receptor binding sites for rhinovirus and ligands for inflammatory cells. The end result is an increase in the inflammatory response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Lymphocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory viruses can provoke specific and non-specific responses in T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/47\">",
"     47",
"    </a>",
"    ]. Natural killer cells, CD4+ T cells, and CD8+ T cells all participate in antiviral immune responses. As an example, CD8+ cells are a major source of TNF-alpha, which is important for antiviral effects, but can also stimulate epithelial cells to express ICAM-1.",
"   </p>",
"   <p>",
"    Virus-specific T cell responses are not detected in the airway or blood until 7 to 10 days following inoculation. The timing of this response raises questions about the role of virus-specific T cells in acute wheezing episodes. In contrast, lung T cells are probably activated in an antigen or virus-independent manner through \"bystander\" effects. As an example, incubation of peripheral blood monocytes with rhinovirus leads to increased expression of the early activation marker, CD69, on approximately 50 percent of T cells. Associated with this response is an increase in mRNA for IFN-gamma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In mice, antigen-independent activation of T cells occurs during systemic viral infection with lymphocytic choriomeningitis virus, a viral surrogate that is used instead of RSV or HRV. Other examples exist and suggest that respiratory viruses can cause non-specific T cell recruitment and activation early in the course of a viral infection. The timing of this response suggests that it could serve to enhance existing airway inflammation and consequently exacerbate underlying asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cytokine release",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viruses most likely enhance allergic inflammation and promote asthma exacerbations through the release of proinflammatory cytokines. A number of investigators have found increased concentrations of cytokines, including interleukin (IL)-1, IL-2, interferon (IFN)-alpha, and IFN-gamma, in nasal aspirates and from activated peripheral blood cells at the time of a cold [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/42,50-53\">",
"     42,50-53",
"    </a>",
"    ]. These observations raise the possibility that rhinovirus either stimulates cytokine production, thereby changing the microenvironment of the lower airway, or enhances the capacity of cells to generate cytokines in response to other stimuli. The end result of this effect on cytokine production is an increased potential for allergic inflammation during an encounter with other factors, such as allergens.",
"   </p>",
"   <p>",
"    Virus-induced wheezing is also linked to deficiencies in antiviral innate immunity, specifically IFN production in response to viral infection. The interferons may play several roles in asthma.",
"   </p>",
"   <p>",
"    Type I interferons (IFN-alpha, IFN-beta) are important in antiviral immunity, and patients with asthma have decreased virus-induced IFN-beta compared with those without asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/54\">",
"     54",
"    </a>",
"    ]. Furthermore, an inverse correlation was found between peak cold symptoms and the IFN-gamma to IL-5 mRNA ratio in atopic subjects with experimental rhinovirus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. The mechanisms for decreased IFN-production are not known, but may be related to deficient expression of Toll-like receptors, such as TLR3 and",
"    <span class=\"nowrap\">",
"     TLR7/8,",
"    </span>",
"    or in molecules involved in signaling cascades.",
"   </p>",
"   <p>",
"    Abnormalities in IFN-lambda production are described in patients with asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/54\">",
"     54",
"    </a>",
"    ]. In vitro research has shown that baseline IFN-lambda",
"    <sub>",
"     1-3",
"    </sub>",
"    production is deficient in bronchial epithelial cells and alveolar macrophages in patients with asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/57\">",
"     57",
"    </a>",
"    ]. A prospective study in school aged children with asthma reported increased IFN-lambda",
"    <sub>",
"     1",
"    </sub>",
"    production in acutely HRV infected wheezing children compared with HRV infected non-wheezers, suggesting that IFN-lambda",
"    <sub>",
"     1",
"    </sub>",
"    production may modulate HRV-induced asthma exacerbations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/58\">",
"     58",
"    </a>",
"    ]. Further research is needed to determine the definitive role of IFN-lamba in virus-induced wheezing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Parasympathetic hyperresponsiveness",
"    </span>",
"    &nbsp;&mdash;&nbsp;In animal studies, other mechanisms have been identified to explain changes in airway function during viral respiratory infections. Two studies in guinea pigs and rats found that viral respiratory infections impair inhibitory M2 muscarinic receptor function, producing parasympathetic hyperresponsiveness that leads to bronchoconstriction [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. This effect may persist for weeks after resolution of the acute infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/60\">",
"     60",
"    </a>",
"    ]. Corticosteroid administration reverses the virus-associated changes in airway function [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Increased IgE",
"    </span>",
"    &nbsp;&mdash;&nbsp;One study demonstrated increases in IgE levels in subjects with allergic rhinitis, but not in subjects with nonallergic rhinitis after experimental rhinovirus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/61\">",
"     61",
"    </a>",
"    ]. Other investigators have shown that RSV and parainfluenza virus can stimulate total IgE and virus-specific IgE in children [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/62-64\">",
"     62-64",
"    </a>",
"    ]. The development of virus-specific IgE levels correlates with the probability of recurrent episodes of wheeze.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     WHEEZING DUE TO VIRAL INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies have shown that viral infections trigger up to 85 percent of asthma exacerbations in school-aged children and up to 50 percent of exacerbations in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. The clinical implications and differential diagnosis of virus-induced wheezing vary with the age of the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Children &lt;2 years of age",
"    </span>",
"    &nbsp;&mdash;&nbsp;A first episode of wheezing in association with a viral respiratory infection leads to an outpatient visit for about 15 percent of all infants in the United States, and 3 percent are hospitalized with this presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. Bronchiolitis, or inflammation of the bronchioles, is a clinical syndrome characterized by wheezing, tachypnea, and hyperinflation of the lungs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/69\">",
"     69",
"    </a>",
"    ]. It is of primary importance in infants and young children less than two years of age. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=see_link&amp;anchor=H7#H7\">",
"     \"Bronchiolitis in infants and children: Clinical features and diagnosis\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      RSV is the most common cause of bronchiolitis and wheezing in this age group. One study examined the causative factors for acute wheezing in infants and children presenting to the emergency department [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/70\">",
"       70",
"      </a>",
"      ]. RSV was the most common infectious agent found in children less than two years of age, and the affected children were nonallergic. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link\">",
"       \"Respiratory syncytial virus infection: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rhinovirus is also a common cause of wheezing and bronchiolitis in infancy, although its prevalence in virus-induced wheezing is more significant in adults and children older than two years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/5,9,71-73\">",
"       5,9,71-73",
"      </a>",
"      ]. The HRV-C serotypes, in addition to HRV-A and HRV-B, are associated with virus-induced wheezing and asthma exacerbations in children [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/74-76\">",
"       74-76",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=see_link&amp;anchor=H199066514#H199066514\">",
"       \"The common cold in children: Clinical features and diagnosis\", section on 'Virology'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19383?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metapneumovirus, another member of the Paramyxoviridae family, can cause upper and lower respiratory tract infection and wheezing in young children [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/77,78\">",
"       77,78",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33304?source=see_link\">",
"       \"Human metapneumovirus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Coronaviruses, bocaviruses, and influenza can also provoke wheezing [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/79-82\">",
"       79-82",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41176?source=see_link\">",
"       \"Coronaviruses\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Risk factors for wheezing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of epidemiologic studies have investigated risk factors for wheezing with respiratory infections and the effect of these illnesses on the eventual development of asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/83-87\">",
"     83-87",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=see_link&amp;anchor=H17#H17\">",
"     \"Risk factors for asthma\", section on 'Respiratory infections'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H16\">",
"     'Development of asthma'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Exposure to cigarette smoke is a major predictor of wheezing in the child less than two years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/88\">",
"       88",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Most infants and young children who wheeze with RSV infection are nonatopic [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/88\">",
"       88",
"      </a>",
"      ]. In addition, many of these children appear to have reduced lung function, which may predispose them to developing wheezing with respiratory infections [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/87,89,90\">",
"       87,89,90",
"      </a>",
"      ]. A prospective analysis of 1246 children, for example, assessed the relationship between initial lung function and the development of a wheezing illness during the first year of life [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/90\">",
"       90",
"      </a>",
"      ]. Infants with low total respiratory conductance had an almost fourfold higher risk of wheezing with viral respiratory infections. These data indicate that lung size is an important factor in the manifestation of wheezing with an RSV infection. Boys generally have smaller lungs than girls, which may explain in part why boys are nearly ten times more likely than girls to wheeze after respiratory infections [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/90\">",
"       90",
"      </a>",
"      ]. Furthermore, infants with lower lung function are at increased risk of airflow obstruction as young adults [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/91\">",
"       91",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Risk factors associated with recurrent wheezing in children aged 12 to 15 months in a cross-sectional study included parental history of asthma, maternal smoking during pregnancy, patient history of bronchopneumonia, daycare attendance, and early exposure to pets [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/92\">",
"       92",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Results from cohort studies have also shown that aeroallergen sensitization and wheezing with RSV and rhinovirus in early childhood are important predictors of the later development of asthma [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/5-9,11,71-73,93,94\">",
"       5-9,11,71-73,93,94",
"      </a>",
"      ]. In addition, the occurrence of rhinovirus-associated wheezing during the first three years of life in a high risk birth cohort was the most significant predictor of the subsequent development of asthma [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Older children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wheezing in the setting of viral respiratory infections becomes less common and has different implications as the child becomes older. Children over two years of age with wheezing episodes after viral infection are more likely than those without virus-induced wheezing to have elevated plasma IgE levels, sensitization to inhalant allergens, and a maternal history of asthma, which suggests a predisposition to asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/83,86,88\">",
"     83,86,88",
"    </a>",
"    ]. Respiratory viruses other than RSV are more common triggers in older children [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/88\">",
"     88",
"    </a>",
"    ]. As an example, rhinovirus was detected in 71 percent of children older than two years of age in an emergency department study of children with acute asthma exacerbations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/70\">",
"     70",
"    </a>",
"    ]. The risk of wheezing with viral infection was greatly increased with evidence of atopy (indicated by increased IgE levels) and eosinophilic inflammation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Differential diagnosis of wheezing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of wheezing in children includes a variety of congenital and acquired conditions (",
"    <a class=\"graphic graphic_table graphicRef67370 \" href=\"UTD.htm?23/40/24204\">",
"     table 2",
"    </a>",
"    ). Different conditions that involve a variety of anatomic airway locations can produce obstruction and expiratory or inspiratory wheezing in adults (",
"    <a class=\"graphic graphic_table graphicRef67704 \" href=\"UTD.htm?10/36/10829\">",
"     table 3",
"    </a>",
"    ). Postnasal drip syndrome, not asthma, was the most common cause of wheeze in adult patients referred to a pulmonary outpatient clinic (",
"    <a class=\"graphic graphic_figure graphicRef73019 \" href=\"UTD.htm?8/1/8221\">",
"     figure 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/45/30424?source=see_link\">",
"     \"Approach to wheezing in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/48/36613?source=see_link\">",
"     \"Diagnosis of wheezing illnesses other than asthma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DEVELOPMENT OF ASTHMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral respiratory infections in infancy, particularly with RSV and HRV, are predictive of the development of asthma in later childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/5-8,11,93,95\">",
"     5-8,11,93,95",
"    </a>",
"    ]. In addition, the timing of birth and the subsequent exposure to peak bronchiolitis and RSV season may influence the development of asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/74,96\">",
"     74,96",
"    </a>",
"    ]. However, it remains unclear whether certain viral respiratory infections cause asthma or if wheezing with these infections are predictors for the subsequent development of asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/97\">",
"     97",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=see_link&amp;anchor=H17#H17\">",
"     \"Risk factors for asthma\", section on 'Respiratory infections'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Respiratory syncytial virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;In infants and children less than two years of age, respiratory infections with respiratory syncytial virus (RSV) are the most common cause of virus-induced wheezing. Many of these children have decreased wheezing during viral infections as they grow older, although RSV infections are viewed as a potential contributor to the development of asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/6-8,98,99\">",
"     6-8,98,99",
"    </a>",
"    ]. RSV lower respiratory infections are risk factors for the development of recurrent wheezing up to age 11 years. The effect beyond that age is undetermined, but may be related to the severity of RSV bronchiolitis during infancy or related to other cofactors such as atopy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/6-8,87,99\">",
"     6-8,87,99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Those children that have persistent symptoms of asthma or that develop asthma after RSV infection usually have other asthma risk factors, such as a maternal history of asthma and elevated IgE levels [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/69,83,89,90,100-105\">",
"     69,83,89,90,100-105",
"    </a>",
"    ]. Findings from a prospective cohort study of premature infants, 146 treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/27/40371?source=see_link\">",
"     palivizumab",
"    </a>",
"    and 171 untreated, suggest that the effect of RSV infection on subsequent recurrent wheezing is independent of atopic predisposition [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/106\">",
"     106",
"    </a>",
"    ]. RSV prophylaxis decreased the risk of recurrent wheezing in children without a family history of atopy, but had no effect in children from atopic families. Precisely how RSV infections are a risk factor in the development of asthma has not been established.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Rhinovirus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rhinovirus (the common cold virus) influences the development of asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/5,69,71\">",
"     5,69,71",
"    </a>",
"    ]. Studies have shown that infants who wheeze with rhinovirus infection have increased risk of recurrent wheeze and asthma at ages three, five, and six [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/9,72,73\">",
"     9,72,73",
"    </a>",
"    ]. In fact, another study showed that wheezing with rhinovirus infection during the first three years of life was a much stronger risk factor for asthma at six years of age than wheezing with RSV infection or aeroallergen sensitization in a high-risk birth cohort [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Individual host factors probably interact with rhinovirus virulence factors in susceptible patients, resulting in an increased risk of developing asthma. As an example, virus-induced wheezing is influenced by the presence of atopy. Studies show that atopic patients have a greatly increased risk of developing wheezing with rhinovirus illness and suffer from increased airway hyperreactivity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/25,70,107\">",
"     25,70,107",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Other viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early studies investigating the relationship between childhood infections and atopy suggested that exposure to certain infections during early childhood may diminish the risk of developing asthma. As examples, a study from West Africa suggested that measles infection early in life may reduce the risk for atopy, while a Japanese study reported an inverse association between positive tuberculin responses and atopy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/100,108,109\">",
"     100,108,109",
"    </a>",
"    ]. However, subsequent studies have not supported these observations, reporting no associations between measles history or BCG vaccination and the development of asthma and allergic diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/110-112\">",
"     110-112",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In regards to viruses, some viral respiratory infections in early childhood may paradoxically decrease the development of asthma. Children with older siblings and children exposed to daycare settings may be less prone to develop asthma, possibly because they are exposed to more viral infections at a younger age [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/113-115\">",
"     113-115",
"    </a>",
"    ]. However, these findings are difficult to interpret, since these studies did not distinguish between upper and lower respiratory infections and were conducted prior to improved methods of viral detection. These are important distinctions, since wheezing with lower respiratory tract infections, particularly with HRV, carries a greater risk for the subsequent development of asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/5,68-70,116,117\">",
"     5,68-70,116,117",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     ASTHMA COMPLICATED BY VIRAL INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral respiratory infections are an important, and probably the most common, cause of increased pulmonary symptoms in children and adults with preexisting asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/69,71,85,86,88,116,118\">",
"     69,71,85,86,88,116,118",
"    </a>",
"    ]. Rhinovirus is the predominant pathogen identified in school aged children and adult patients with acute asthma exacerbations. Infection with rhinovirus group C is associated with more severe disease in children admitted for asthma exacerbations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/119-121\">",
"     119-121",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Asthma exacerbations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral upper respiratory infections (URIs or colds) are the most frequent cause of asthma exacerbations. One community study, for example, was conducted to identify the role of viral infections in asthma exacerbations in 9 to 11 year old children [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/65\">",
"     65",
"    </a>",
"    ]. In this study, 108 children were followed for 13 months, during which episodes of wheezing were documented and nasal specimens obtained for culture and PCR analysis for viruses. The following results were observed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Viruses were detected in over 80 percent of the episodes of reduced peak flow and wheezing.",
"     </li>",
"     <li>",
"      Increased symptoms of asthma usually occurred within 48 hours of developing an upper respiratory infection and persisted for at least two weeks.",
"     </li>",
"     <li>",
"      The most commonly identified virus was rhinovirus, accounting for approximately 60 percent of infections and wheezing episodes. Rhinovirus may contribute to seasonal asthma morbidity. One-third to one-half of weekly respiratory isolates obtained from six to eight year olds with asthma contained detectable virus, with 72 to 99 percent of the viruses identified as HRV [",
"      <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A more subjective study of 138 adult patients with asthma found that colds were reported during 80 percent",
"    <span class=\"nowrap\">",
"     (223/280)",
"    </span>",
"    of episodes of wheezing, chest tightness, or breathlessness; and 89 percent",
"    <span class=\"nowrap\">",
"     (223/250)",
"    </span>",
"    of colds were associated with asthma symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Asthma hospitalizations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral infections, with human rhinovirus in particular, are the leading cause of increased rates of hospitalization for asthma that are consistently observed in late summer and early fall in many countries, including the United States, Canada, Mexico, and Israel [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/117,122,123\">",
"     117,122,123",
"    </a>",
"    ]. As an example, a Canadian study documented that asthma hospitalizations among school aged children increased predictably after return to school following summer vacation and other breaks [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/124\">",
"     124",
"    </a>",
"    ]. Specifically, a \"September asthma epidemic\" is observed in this age group during the third week of the month, with lesser increases in asthma admissions two days later in preschool children, and six days later in adults, consistent with transmission of viral infections (",
"    <a class=\"graphic graphic_figure graphicRef60106 \" href=\"UTD.htm?10/63/11249\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A similar peak in asthma hospitalization caused by rhinovirus infection is seen in the southern hemisphere in April, which also coincides with the onset of the school year [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/125\">",
"     125",
"    </a>",
"    ]. A winter peak is primarily due to RSV and a spring peak is caused by both RSV and rhinovirus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Infection susceptibility and severity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with asthma do not appear to be more susceptible to rhinovirus infection than healthy controls. However, they do appear to be at greater risk for developing more severe and prolonged lower respiratory tract symptoms with infection. This was illustrated in a longitudinal cohort study of 76 cohabitating couples, one with and one without atopic asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/126\">",
"     126",
"    </a>",
"    ]. The participants underwent serial evaluations both for symptoms and virologic evidence of infection. Asthma was not associated with an increased risk of rhinovirus infection or with the severity or duration of virus-induced upper respiratory tract symptoms. In contrast, those with asthma were more likely to have lower respiratory tract infections with more protracted and severe symptoms.",
"   </p>",
"   <p>",
"    In another study, respiratory specimens from school aged children with acute asthma exacerbations (cases) were compared with children with well-controlled asthma (controls) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/15/2298/abstract/127\">",
"     127",
"    </a>",
"    ]. Viral infection, particularly rhinovirus infection, was more common in cases than controls (63 versus 23 percent, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Viral respiratory infections, particularly with respiratory syncytial virus (RSV) and human rhinovirus (HRV), are the most common causes of wheezing in infants and young children and they have important influences on the development of asthma. In addition, viral infections, most often with rhinovirus, are the most common causes of wheezing or increased symptoms in patients with preexisting asthma. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Respiratory viruses interact with host factors to promote virus-induced wheezing and asthma exacerbations via a number of mechanisms including increased recruitment of inflammatory cells, promotion of cytokine production, enhancement of allergic inflammation, and augmented airways hyperresponsiveness. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and wheezing in children &lt;2 years of age. Exposure to tobacco smoke and reduced lung function are risk factors associated with virus-induced wheezing in this age group. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Wheezing due to viral infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Wheezing with viral respiratory infections, particularly with RSV and HRV, are important predictors of the subsequent development of asthma. However, it is unclear whether certain viral respiratory infections cause asthma or if wheezing with these infections is a predictor of childhood asthma. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Development of asthma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Viral respiratory infections are an important, and probably the most common, cause of increased pulmonary symptoms in children and adults with preexisting asthma. Rhinovirus is the predominant pathogen and the most frequent trigger of virus-induced asthma exacerbations in patients with asthma. Patients with asthma do not appear to be more susceptible to rhinovirus infection than healthy controls. However, they are at greater risk of developing more severe and prolonged lower respiratory tract symptoms with infection. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Asthma complicated by viral infection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/1\">",
"      Carroll KN, Hartert TV. The impact of respiratory viral infection on wheezing illnesses and asthma exacerbations. Immunol Allergy Clin North Am 2008; 28:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/2\">",
"      Tan WC. Viruses in asthma exacerbations. Curr Opin Pulm Med 2005; 11:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/3\">",
"      MacDowell AL, Bacharier LB. Infectious triggers of asthma. Immunol Allergy Clin North Am 2005; 25:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/4\">",
"      Le Sou&euml;f PN. Gene-environmental interaction in the development of atopic asthma: new developments. Curr Opin Allergy Clin Immunol 2009; 9:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/5\">",
"      Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/6\">",
"      Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161:1501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/7\">",
"      Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005; 171:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/8\">",
"      Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/9\">",
"      Kusel MM, de Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/10\">",
"      Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 2012; 18:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/11\">",
"      Gern JE. Viral respiratory infection and the link to asthma. Pediatr Infect Dis J 2008; 27:S97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/12\">",
"      Olenec JP, Kim WK, Lee WM, et al. Weekly monitoring of children with asthma for infections and illness during common cold seasons. J Allergy Clin Immunol 2010; 125:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/13\">",
"      Palmenberg AC, Rathe JA, Liggett SB. Analysis of the complete genome sequences of human rhinovirus. J Allergy Clin Immunol 2010; 125:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/14\">",
"      Becker S, Quay J, Soukup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 1991; 147:4307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/15\">",
"      Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995; 96:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/16\">",
"      Becker S, Koren HS, Henke DC. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am J Respir Cell Mol Biol 1993; 8:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/17\">",
"      Einarsson O, Panusak J, Zhu Z, et al. Respiratory syncytial virus stimulation of interleukin-11 production by airway epithelial cells and lung fibroblasts. Am J Respir Crit Care Med 1994; 149:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/18\">",
"      Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 1993; 265:L472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/19\">",
"      Garofalo R, Mei F, Espejo R, et al. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol 1996; 157:2506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/20\">",
"      Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol 2010; 125:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/21\">",
"      Papi A, Stanciu LA, Papadopoulos NG, et al. Rhinovirus infection induces major histocompatibility complex class I and costimulatory molecule upregulation on respiratory epithelial cells. J Infect Dis 2000; 181:1780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/22\">",
"      Douglas RG Jr, Alford BR, Couch RB. Atraumatic nasal biopsy for studies of respiratory virus infection in volunteers. Antimicrob Agents Chemother (Bethesda) 1968; 8:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/23\">",
"      Winther B, Farr B, Turner RB, et al. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol Suppl 1984; 413:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/24\">",
"      Fraenkel DJ, Bardin PG, Sanderson G, et al. Immunohistochemical analysis of nasal biopsies during rhinovirus experimental colds. Am J Respir Crit Care Med 1994; 150:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/25\">",
"      Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994; 94:2200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/26\">",
"      Lemanske RF Jr, Dick EC, Swenson CA, et al. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989; 83:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/27\">",
"      Avila PC, Abisheganaden JA, Wong H, et al. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold. J Allergy Clin Immunol 2000; 105:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/28\">",
"      Fraenkel DJ, Bardin PG, Sanderson G, et al. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995; 151:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/29\">",
"      Gern JE, Galagan DM, Jarjour NN, et al. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997; 155:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/30\">",
"      Folkerts G, Busse WW, Nijkamp FP, et al. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998; 157:1708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/31\">",
"      Jarjour NN, Gern JE, Kelly EA, et al. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 2000; 105:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/32\">",
"      Denlinger LC, Sorkness RL, Lee WM, et al. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation. Am J Respir Crit Care Med 2011; 184:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/33\">",
"      Arnold R, Humbert B, Werchau H, et al. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 1994; 82:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/34\">",
"      Gr&uuml;nberg K, Timmers MC, Smits HH, et al. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy 1997; 27:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/35\">",
"      Teran LM, Johnston SL, Schr&ouml;der JM, et al. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med 1997; 155:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/36\">",
"      Zhou S, Stark JM, Leikauf GD. Leukotriene B4 formation: human neutrophil-airway epithelial cell interactions. J Appl Physiol 1995; 78:1396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/37\">",
"      Fiedler MA, Wernke-Dollries K, Stark JM. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am J Physiol 1995; 269:L865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/38\">",
"      Garofalo R, Kimpen JL, Welliver RC, Ogra PL. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992; 120:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/39\">",
"      Rakes GP, Arruda E, Ingram JM, et al. Assessment of viral pathogens and eosinophilic cationic protein in nasal washes form wheezing infants and children. Am J Respir Crit Care Med 1995; 151:A362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/40\">",
"      Seminario MC, Squillace D, Bardin PG, et al. Increased levels of eosinophil major basic protein in nasal secretions in rhinovirus infection. J Allergy Clin Immunol 1995; 95:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/41\">",
"      Volovitz B, Welliver RC, De Castro G, et al. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 1988; 24:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/42\">",
"      Proud D, Gwaltney JM Jr, Hendley JO, et al. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis 1994; 169:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/43\">",
"      Noah TL, Henderson FW, Wortman IA, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995; 171:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/44\">",
"      Gern JE, Dick EC, Lee WM, et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 1996; 156:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/45\">",
"      Roberts NJ Jr, Prill AH, Mann TN. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity. J Exp Med 1986; 163:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/46\">",
"      Johnston SL, Papi A, Monick MM, Hunninghake GW. Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. J Infect Dis 1997; 175:323.",
"     </a>",
"    </li>",
"    <li>",
"     Gern JE, Busse WW. Role of T cells in virus-induced asthma. In: The Genetics of Asthma, Liggett SB, Meyers DA (Eds), Marcel Dekker, New York 1996. p.39.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/48\">",
"      Gern JE, Vrtis R, Kelly EA, et al. Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J Immunol 1996; 157:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/49\">",
"      Riese RJ, Finn PW, Shapiro SD. Influenza and asthma: adding to the respiratory burden. Nat Immunol 2004; 5:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/50\">",
"      Proud D, Naclerio RM, Gwaltney JM, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis 1990; 161:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/51\">",
"      Hsia J, Goldstein AL, Simon GL, et al. Peripheral blood mononuclear cell interleukin-2 and interferon-gamma production, cytotoxicity, and antigen-stimulated blastogenesis during experimental rhinovirus infection. J Infect Dis 1990; 162:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/52\">",
"      Linden M, Greiff L, Andersson M, et al. Nasal cytokines in common cold and allergic rhinitis. Clin Exp Allergy 1995; 25:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/53\">",
"      Levandowski RA, Horohov DW. Rhinovirus induces natural killer-like cytotoxic cells and interferon alpha in mononuclear leukocytes. J Med Virol 1991; 35:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/54\">",
"      Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/55\">",
"      Gern JE, Vrtis R, Grindle KA, et al. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000; 162:2226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/56\">",
"      Brooks GD, Buchta KA, Swenson CA, et al. Rhinovirus-induced interferon-gamma and airway responsiveness in asthma. Am J Respir Crit Care Med 2003; 168:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/57\">",
"      Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006; 12:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/58\">",
"      Miller EK, Hernandez JZ, Wimmenauer V, et al. A mechanistic role for type III IFN-&lambda;1 in asthma exacerbations mediated by human rhinoviruses. Am J Respir Crit Care Med 2012; 185:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/59\">",
"      Fryer AD, Jacoby DB. Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 1991; 102:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/60\">",
"      Sorkness R, Clough JJ, Castleman WL, Lemanske RF Jr. Virus-induced airway obstruction and parasympathetic hyperresponsiveness in adult rats. Am J Respir Crit Care Med 1994; 150:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/61\">",
"      Skoner DP, Doyle WJ, Tanner EP, et al. Effect of rhinovirus 39 (RV-39) infection on immune and inflammatory parameters in allergic and non-allergic subjects. Clin Exp Allergy 1995; 25:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/62\">",
"      Welliver RC, Wong DT, Sun M, et al. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981; 305:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/63\">",
"      Welliver RC, Wong DT, Middleton E Jr, et al. Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr 1982; 101:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/64\">",
"      Welliver RC, Kaul TN, Ogra PL. The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. N Engl J Med 1980; 303:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/65\">",
"      Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/66\">",
"      Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/67\">",
"      Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/68\">",
"      Centers for Disease Control and Prevention (CDC). Bronchiolitis-associated outpatient visits and hospitalizations among American Indian and Alaska Native children--United States, 1990-2000. MMWR Morb Mortal Wkly Rep 2003; 52:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/69\">",
"      Stark JM, Busse WW. Respiratory virus infection and airway hyperreactivity in children. Pediatr Allergy Immunol 1991; 2:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/70\">",
"      Rakes GP, Arruda E, Ingram JM, et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med 1999; 159:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/71\">",
"      Jackson DJ. The role of rhinovirus infections in the development of early childhood asthma. Curr Opin Allergy Clin Immunol 2010; 10:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/72\">",
"      Lemanske RF Jr, Jackson DJ, Gangnon RE, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005; 116:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/73\">",
"      Roberg KA, Sullivan-Dillie KT, Evans MD, et al. Wheezing severe rhinovirus illnesses during infancy predict childhood asthma at age 6 years. J Allergy Clin Immunol 2007; 119:S157 (Abstract).",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/74\">",
"      Rosenthal LA, Avila PC, Heymann PW, et al. Viral respiratory tract infections and asthma: the course ahead. J Allergy Clin Immunol 2010; 125:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/75\">",
"      Miller EK, Edwards KM, Weinberg GA, et al. A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol 2009; 123:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/76\">",
"      Lee WM, Kiesner C, Pappas T, et al. A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS One 2007; 2:e966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/77\">",
"      van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/78\">",
"      Boivin G, Abed Y, Pelletier G, et al. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 2002; 186:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/79\">",
"      Edwards KM, Thompson J, Paolini J, Wright PF. Adenovirus infections in young children. Pediatrics 1985; 76:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/80\">",
"      Esper F, Weibel C, Ferguson D, et al. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis 2005; 191:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/81\">",
"      Foulongne V, Rodi&egrave;re M, Segondy M. Human Bocavirus in children. Emerg Infect Dis 2006; 12:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/82\">",
"      Mansbach JM, Camargo CA Jr. Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma. Clin Lab Med 2009; 29:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/83\">",
"      Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy 1992; 22:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/84\">",
"      Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/85\">",
"      Bardin PG, Johnston SL, Pattemore PK. Viruses as precipitants of asthma symptoms. II. Physiology and mechanisms. Clin Exp Allergy 1992; 22:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/86\">",
"      Sterk PJ. Virus-induced airway hyperresponsiveness in man. Eur Respir J 1993; 6:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/87\">",
"      Gern JE, Rosenthal LA, Sorkness RL, Lemanske RF Jr. Effects of viral respiratory infections on lung development and childhood asthma. J Allergy Clin Immunol 2005; 115:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/88\">",
"      Duff AL, Pomeranz ES, Gelber LE, et al. Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics 1993; 92:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/89\">",
"      Martinez FD, Morgan WJ, Wright AL, et al. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/90\">",
"      Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/91\">",
"      Stern DA, Morgan WJ, Wright AL, et al. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007; 370:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/92\">",
"      Chong Neto HJ, Rosario N, Sol&eacute; D, Mallol J. Associated factors for recurrent wheezing in infancy. Allergy 2010; 65:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/93\">",
"      Kotaniemi-Syrj&auml;nen A, Vainionp&auml;&auml; R, Reijonen TM, et al. Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma? J Allergy Clin Immunol 2003; 111:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/94\">",
"      Sly PD, Kusel M, Holt PG. Do early-life viral infections cause asthma? J Allergy Clin Immunol 2010; 125:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/95\">",
"      Carroll KN, Wu P, Gebretsadik T, et al. Season of infant bronchiolitis and estimates of subsequent risk and burden of early childhood asthma. J Allergy Clin Immunol 2009; 123:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/96\">",
"      Wu P, Dupont WD, Griffin MR, et al. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med 2008; 178:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/97\">",
"      Bartlett NW, McLean GR, Chang YS, Johnston SL. Genetics and epidemiology: asthma and infection. Curr Opin Allergy Clin Immunol 2009; 9:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/98\">",
"      Gern JE. Rhinovirus and the initiation of asthma. Curr Opin Allergy Clin Immunol 2009; 9:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/99\">",
"      Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010; 65:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/100\">",
"      Shaheen SO. Changing patterns of childhood infection and the rise in allergic disease. Clin Exp Allergy 1995; 25:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/101\">",
"      Cypcar D, Busse WW. Role of viral infections in asthma. Immunol Allergy Clin North Am 1993; 13:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/102\">",
"      Sigurs N, Bjarnason R, Sigurbergsson F, et al. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995; 95:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/103\">",
"      Cogswell JJ, Halliday DF, Alexander JR. Respiratory infections in the first year of life in children at risk of developing atopy. Br Med J (Clin Res Ed) 1982; 284:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/104\">",
"      Welliver RC. RSV and chronic asthma. Lancet 1995; 346:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/105\">",
"      Bacharier LB, Cohen R, Schweiger T, et al. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 2012; 130:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/106\">",
"      Sim&otilde;es EA, Carbonell-Estrany X, Rieger CH, et al. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol 2010; 126:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/107\">",
"      Jartti T, Kuusipalo H, Vuorinen T, et al. Allergic sensitization is associated with rhinovirus-, but not other virus-, induced wheezing in children. Pediatr Allergy Immunol 2010; 21:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/108\">",
"      Alm JS, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy. Lancet 1997; 350:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/109\">",
"      Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau. Lancet 1996; 347:1792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/110\">",
"      Paunio M, Heinanen OP, Virtanen M, et al. Measles history and atopic diseases: a population based cross-sectional study. JAMA 2000; 283:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/111\">",
"      Gr&uuml;ber C, Kulig M, Bergmann R, et al. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early Bacille Calmette-Gu&eacute;rin-vaccinated and nonvaccinated children. Pediatrics 2001; 107:E36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/112\">",
"      Krause TG, Hviid A, Koch A, et al. BCG vaccination and risk of atopy. JAMA 2003; 289:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/113\">",
"      von Mutius E, Martinez FD, Fritzsch C, et al. Skin test reactivity and number of siblings. BMJ 1994; 308:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/114\">",
"      Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/115\">",
"      Strachan DP, Harkins LS, Johnston ID, Anderson HR. Childhood antecedents of allergic sensitization in young British adults. J Allergy Clin Immunol 1997; 99:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/116\">",
"      Tan WC, Xiang X, Qiu D, et al. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 2003; 115:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/117\">",
"      Bates DV, Baker-Anderson M, Sizto R. Asthma attack periodicity: a study of hospital emergency visits in Vancouver. Environ Res 1990; 51:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/118\">",
"      Johnston SL, Bardin PG, Pattemore PK. Viruses as precipitants of asthma symptoms. III. Rhinoviruses: molecular biology and prospects for future intervention. Clin Exp Allergy 1993; 23:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/119\">",
"      Bizzintino J, Lee WM, Laing IA, et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 2011; 37:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/120\">",
"      Mak RK, Tse LY, Lam WY, et al. Clinical spectrum of human rhinovirus infections in hospitalized Hong Kong children. Pediatr Infect Dis J 2011; 30:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/121\">",
"      Iwane MK, Prill MM, Lu X, et al. Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis 2011; 204:1702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/122\">",
"      Weiss KB. Seasonal trends in US asthma hospitalizations and mortality. JAMA 1990; 263:2323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/123\">",
"      Kimes D, Levine E, Timmins S, et al. Temporal dynamics of emergency department and hospital admissions of pediatric asthmatics. Environ Res 2004; 94:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/124\">",
"      Johnston NW, Johnston SL, Norman GR, et al. The September epidemic of asthma hospitalization: school children as disease vectors. J Allergy Clin Immunol 2006; 117:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/125\">",
"      Maffey AF, Barrero PR, Venialgo C, et al. Viruses and atypical bacteria associated with asthma exacerbations in hospitalized children. Pediatr Pulmonol 2010; 45:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/126\">",
"      Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002; 359:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/15/2298/abstract/127\">",
"      Khetsuriani N, Kazerouni NN, Erdman DD, et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 2007; 119:314.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 535 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-C0B5FDA9AB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2298=[""].join("\n");
var outline_f2_15_2298=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Epithelial Cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Airway inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Granulocytes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Macrophages and monocytes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Lymphocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cytokine release",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Parasympathetic hyperresponsiveness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Increased IgE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      WHEEZING DUE TO VIRAL INFECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Children &lt;2 years of age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Risk factors for wheezing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Older children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Differential diagnosis of wheezing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DEVELOPMENT OF ASTHMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Respiratory syncytial virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Rhinovirus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Other viruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      ASTHMA COMPLICATED BY VIRAL INFECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Asthma exacerbations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Asthma hospitalizations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Infection susceptibility and severity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/535\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/535|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/33/18974\" title=\"figure 1\">",
"      Viruses and host factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/41/25247\" title=\"figure 2\">",
"      RV and late asthmatic reaction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/1/8221\" title=\"figure 3\">",
"      Wheezing frequency and causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/63/11249\" title=\"figure 4\">",
"      Sept asthma epidemic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/535|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/22/14700\" title=\"table 1\">",
"      Virus induced airway obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/40/24204\" title=\"table 2\">",
"      Causes of wheeze in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/36/10829\" title=\"table 3\">",
"      Major causes of wheeze",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/45/30424?source=related_link\">",
"      Approach to wheezing in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=related_link\">",
"      Bronchiolitis in infants and children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=related_link\">",
"      Clinical features and diagnosis of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41176?source=related_link\">",
"      Coronaviruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/48/36613?source=related_link\">",
"      Diagnosis of wheezing illnesses other than asthma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19383?source=related_link\">",
"      Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33304?source=related_link\">",
"      Human metapneumovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7383?source=related_link\">",
"      Natural history of asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4937?source=related_link\">",
"      Pathogenesis of asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=related_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=related_link\">",
"      Risk factors for asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=related_link\">",
"      The common cold in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/44/22216?source=related_link\">",
"      Treatment of recurrent virus-induced wheezing in young children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_15_2299="Renal sx in hyperparathyroidism";
var content_f2_15_2299=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F65839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F65839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Renal manifestations of primary hyperparathyroidism",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Decreased glomerular filtration rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypercalciuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nephrolithiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nephrocalcinosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Impaired urinary concentrating ability sometimes leading to polyuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduced fractional phosphate reabsorption leading to hypophosphatemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased urinary excretion of magnesium",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2299=[""].join("\n");
var outline_f2_15_2299=null;
var title_f2_15_2300="Etiology of seizures in children with cancer";
var content_f2_15_2300=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65165&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiology of seizures in children with cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Primary CNS tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metastatic tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leukemic meningitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperleukocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        CNS infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Viral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bacterial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fungal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Protozoal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cerebrovascular accident",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intrathecal methotrexate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intrathecal cytosine arabinoside",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        L-asparaginase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vincristine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Metabolic abnormality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyponatremia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypocalcemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypoglycemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hypoxia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CNS: central nervous system.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rheingold SR, Lange BJ. Oncologic Emergencies. In: Principles and Practice of Pediatric Oncology, 5th ed, Pizzo PA, Poplack DG (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2300=[""].join("\n");
var outline_f2_15_2300=null;
var title_f2_15_2301="Rx CDAD";
var content_f2_15_2301=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F53273&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F53273&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment of non-severe Clostridium difficile associated diarrhea in adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Initial episode",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mild disease: metronidazole 500 mg orally three times daily or 250 mg four times daily for 10 to 14 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe disease: vancomycin 125 mg orally four times daily for 10 to 14 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        First relapse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Confirm diagnosis (see text)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If symptoms are mild, conservative management may be appropriate.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If antibiotics are needed, repeat treatment as in initial episode above. Alternative: fidaxomicin 200 mg orally twice daily for 10 days",
"        <sup>",
"         [4,5]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Second relapse",
"        <sup>",
"         [1,2]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Confirm diagnosis (see text)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Tapering and pulsed oral vancomycin (below), with or without probiotics (for example, Saccharomyces boulardii 500 mg orally twice daily). The probiotics may be overlapped with the final week of the taper and continued for two additional weeks in the absence of antibiotics.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        125 mg orally four times daily for 7 to 14 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        125 mg orally twice daily for 7 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        125 mg orally once daily for 7 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        125 mg orally every other day for 7 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        125 mg orally every 3 days for 14 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alternative: fidaxomicin 200 mg orally twice daily for 10 days",
"        <sup>",
"         [4,5]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Subsequent relapse",
"        <sup>",
"         [3,4]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Confirm diagnosis (see text)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fidaxomicin 200 mg orally twice daily for 10 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alternative: Vancomycin 125 mg orally four times daily for 14 days, followed by rifaximin 400 mg twice daily for 14 days",
"        <sup>",
"         [6]",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Tedesco FJ, Gordon D, Fortson WC. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1985; 80:867.",
"       </li>",
"       <li>",
"        Cohen SH, Gerding DN, Johnson S, et al: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31(5):431-455.",
"       </li>",
"       <li>",
"        Johnson S, Schriever C, Galang M, et al. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 2007; 44:846.",
"       </li>",
"       <li>",
"        Louie TJ, et al: Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011; 364:422-31.",
"       </li>",
"       <li>",
"        Cornely OA, Miller MA, Louie TJ, et al. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.&nbsp;Clin Infect Dis 2012; 55 Suppl 2:S154.&nbsp;&nbsp;",
"       </li>",
"       <li>",
"        Garey KW, Ghantoji SS, Shah DN, et al. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother 2011; 66:2850.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2301=[""].join("\n");
var outline_f2_15_2301=null;
var title_f2_15_2302="Eval of pituitary incidentaloma";
var content_f2_15_2302=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F80461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F80461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 492px\">",
"   <div class=\"ttl\">",
"    Approach to the patient with an incidental signal abnormality on MRI of the pituitary gland",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 472px; height: 302px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2302=[""].join("\n");
var outline_f2_15_2302=null;
var title_f2_15_2303="Retrograde pyelogram in RPN";
var content_f2_15_2303=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F74530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F74530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Retrograde pyelogram showing papillary necrosis in analgesic nephropathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 183px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Retrograde pyelogram showing papillary necrosis in analgesic abuse nephropathy. All the calyces are abnormal with complete papillary necrosis in the lower calyx and partial papillary necrosis in the other calyces. One medullary ring is present (large arrow) in which the clear area represents a portion of the sloughed papilla that has remained in place. The upper calyces show cavities of different sizes due to partial sloughing of the papillae (small arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Harrow, BR, Sloane, JA, Liebman, NC, JAMA 1963; 184:445. By permission of the American Medical Association, copyright 1963.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_15_2303=[""].join("\n");
var outline_f2_15_2303=null;
